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Abstract 
 
Background 
Systematic reviews are used as the ‘gold standard’ to evaluate healthcare, 
education, and social policies. They are integral to the clinical decision making of 
healthcare professionals, and funding decisions made by governmental agencies. 
The rapid growth in primary research has not been matched by a growth in the 
efficiency of producing systematic reviews and consequently evidence-based 
decision making is struggling to remain feasible. 
 
Aims 
This body of research aimed to develop and evaluate strategies towards the 
automation of systematic reviews, so that secondary health research can be 
produced more efficiently and cost effectively. To that end, four research studies 
were developed: 1. Comparing the performance of biomedical databases to 
determine the sensitivity and precision for identifying systematic reviews; 2. 
Developing and evaluating algorithms to detect duplicate records arising from 
searching biomedical databases; 3. Evaluating the potential benefits from using a 
semi-automated machine learning predictive algorithm for citation screening; 4. 
Developing and evaluating strategies to expedite citation screening using title-only 
keyword searching. 
 
Methods 
Different methods were used to answer the research questions. For the first 
research study (identifying reviews), 7 biomedical databases were searched for 
systematic reviews of any intervention for hypertension and the performance of 
each database was assessed and compared for both comprehensiveness and 
accuracy. For the second research study (deduplication), an iterative approach was 
needed to develop and evaluate the performance of each algorithm to detect 
duplicates; the results acquired from each algorithm were used to inform the next 
iteration until an ideal algorithm was produced that achieved higher duplicate 
detection than current methods, but without compromising accuracy. For the third 
research study (predictive screening), 4 datasets from the literature searches of 
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published systematic reviews were used to evaluate an online machine learning 
predictive algorithm by replicating the screening decisions of the original reviews; 
sensitivity analyses were performed to determine if the reduction in screening effort 
could be further improved by including non-relevant citations that were closely 
matched to the review inclusion criteria. For the fourth study (expediting screening), 
10 datasets from the literature searches of published systematic reviews were used 
to evaluate title-only screening. Datasets were screened using title-only keywords 
searching based upon the inclusion criteria of each systematic review. The results 
were compared against the published reviews for reduction in screening effort and 
recall of included studies. 
 
Results 
In the first study, the biomedical database, EMBASE, retrieved the largest number 
of relevant citations (69% sensitivity), but also was the least specific (7% specificity), 
retrieving many irrelevant citations. The Cochrane Library had 60% sensitivity and 
was the most precise (30%) of all the databases. None of the databases identified 
all the relevant records, but a combination of EMBASE, the Cochrane Library and 
Epistemonikos identified 83% of all the relevant systematic reviews.  
  In the second study, the iteratively developed deduplication algorithm increased 
duplicate detection by an average of 42% compared with duplicate detection using 
EndNote™ bibliographic reference management software. Additionally, all unique 
citations were correctly classified, whereas EndNote™ classified some unique 
citations wrongly as duplicate records. 
  In study 3, the evaluation found that the predictive screening tool (Abstrackr) 
reduced the screening effort in a range from 9% to 57% depending on the 
complexity of the systematic review. The reliability to retrieve included studies was 
good, with most relevant citations found, but in 2 datasets one included study was 
not retrieved by Abstrackr. Sensitivity analyses found that workload savings could 
be further increased by including closely matched non-relevant citations, and very 
large datasets (≥15,000 citations) could achieve as much as 80% reduction in 
screening. 
   In study 4, the interest was to reduce screening effort using title-only screening. 
This ranged from 11% to 78% with a median reduction in screening effort of 53%. In 
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9 systematic reviews the recall of included studies was 100%. In one review, 4 of 5 
reviewers did not identify the same included study (median recall: 67%, total 
included studies n=3). 
 
Discussion and implications 
Automation tools are increasingly being developed and interest in the subject 
continues to grow with new automation methods and literature overviews being 
published. Some of the automation tools have not been fully tested and this is likely 
to be a barrier to implementation by systematic reviewers. Other tools show promise 
but have not been developed into consumer level products. As a response to these 
challenges, working parties have been established to overcome these barriers and 
establish a set of principles and goals. The findings from this body of research have 
shown that more efficient working practices are possible through improved duplicate 
detection and can be made available to the systematic review community without a 
prolonged research and development period.  The clear potential for machine 
learning algorithms to automate decisions and reduce screening was demonstrated, 
but has not been realised into a consumer ready product, and therefore is worthy of 
further research and development.  Biomedical databases offer different products 
which vary in scale and content and researchers should be prepared to search 
several databases rather than relying on a single database.  The title-only screening 
developed during this research was shown to be effective and demonstrated similar 
reliability to both predictive screening tools and human screening, and could be 
used with other automation tools to assist with screening. Progress with automation 
tools will be accelerated once technical barriers are overcome, and by pursuing 
proof of concept technologies into consumer ready products and thoroughly 
evaluating automation tools for reliability.  
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“In 18th century England, James Hargreaves [an illiterate weaver] invented the 
Spinning Jenny, and Richard Arkwright [wig maker & inventor] pioneered the water-
propelled spinning frame which led to the mass production [automation] of cotton. 
This was truly revolutionary. The cotton manufacturers created a whole new class of 
people - the urban proletariat. The structure of society itself would never be the 
same." 
 
A. N. Wilson on Society 
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Chapter 1 
Introduction 
 
The aim of this PhD is to develop and evaluate automation methods to reduce the 
time and therefore the costs of conducting systematic reviews and other forms of 
evidence synthesis such as rapid reviews, meta-analyses and evidence overviews 
such as scoping searches. There are various definitions of what constitutes a 
systematic review, but in general a systematic review can be defined as aiming to 
identify and appraise all published and non-published evidence, using explicit and 
predefined methodological criteria to minimize bias and to synthesize and report the 
findings in a transparent manner that is open to criticism and correction from peers. 
There are several key steps to undertaking a systematic review (Figure 1) and much 
of the process is time intensive. Clinicians use systematic reviews to guide clinical 
decision making and they can also be used by policy makers to inform funding and 
policy decisions. In the hierarchy of evidence, systematic reviews are considered as 
the ‘gold standard’ for evaluating healthcare interventions. Scoping searches are 
often used to assess the size and scope of the research literature as a preliminary 
step to conducting a systematic review. Rapid reviews are a form of knowledge 
synthesis where some components of the systematic review process are simplified 
or omitted entirely in order to expedite the production of information1.  
 
Since the 18th century automation technologies have increasingly been applied to 
manufacturing to increase production2. In modern society, automation has been 
applied to various business sectors such as the automobile industry (robotic 
welding), air travel (fly-by-wire), retail industry (bar code scanners), and restaurants 
(touch screen ordering & conveyer-belt table service). Ideas that were once 
confined to the realm of science fiction are now realised such as automated postal 
delivery with drones3, and driverless cars controlled by satellite navigation4.  
Healthcare is also benefiting from automation with IBM developing an artificial 
intelligence supercomputer for detecting lung cancer5,6. In contrast, the production 
of systematic reviews continues to rely considerably on human input and has not 
seen the same progress. Organisations are continuing to rely upon inefficient 
working practices that requires considerable human input. 
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Formulate a question
Check question is not already answered 
Compare biomedical databases (study 1)
Develop Protocol
Pre‐state method (inclusion criteria, search strategy,
data extraction, outcomes, statistical analysis)
Search for studies 
Medline, EMBASE, Cochrane Central, grey literature,
contact authors/manufacturers

Remove duplicate citations  (study 2)
Screen citations for relevance 
Abstrackr machine learning evaluation (study 3)
PICo based title‐only screening (study 4)
Data extraction

Quality Assessment & Data Analysis
Write report
Interpret and communicate findings to stakeholders
 Figure 1. Key steps for conducting a systematic review and where studies for this 
                PhD are focussed 
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1.1 History and development of systematic review 
Prior to the development of systematic reviews the practice of healthcare was 
mostly opinion-based rather than evidence based. Criticism of this situation was first 
made by Archie Cochrane who, in 1971, wrote a report evaluating the UK National 
Health Service ‘Effectiveness and Efficiency: Random Reflections on Health 
Services‘7. In it he expressed concern that medicine should be based upon scientific 
evidence rather than the expert opinion of clinicians. His solution was to propose 
that medicine should be organised by specialty and sub-speciality and produce 
critical summaries that are adapted periodically of all relevant randomised controlled 
trials7. However, it took over twenty years before Archie Cochrane’s vision 
commenced with the opening in 1992 of the United Kingdom Cochrane centre in 
Oxford. It has responsibility for the other UK and Ireland Cochrane groups, and for 
collaboration with different healthcare stake holders including the UK Department of 
Health, UK National Institute for Health Research and Oxford University. It was the 
first of 53 Cochrane groups to be founded within the international not for profit 
collaboration that now has contributors and centres from more than 100 countries.  
 
1.2 Advantages of systematic reviews 
Systematic reviews have the potential to detect the benefits and harms of 
healthcare interventions that otherwise might go undetected among a group of 
apparently conflicting individual trials. Trials cited selectively can contradict other 
studies and relying on just a subset of evidence from highly cited studies can 
inaccurately estimate the benefits and harms of treatment8. Similar trials are 
analysed together using statistical methods, known as meta-analysis, which 
incorporate the results of all studies into a single meta-calculation and thus 
increasing the power to detect the benefits or harms of healthcare interventions9. 
Such is the importance of systematic reviews that funding bodies are increasingly 
insisting that a systematic review must be performed as part of a clinical trial 
application to determine whether research gaps exist to justify funding further 
research10. Systematic reviews have the potential to save lives and resources. The 
earliest example, in healthcare, was a systematic review examining the effects of 
post-operative irradiation in women with early-stage breast cancer11. The 5 studies 
pooled together found that 5-year survival rates worsened with irradiation. The 
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effects of bad healthcare advice when applied to large populations can be 
devastating. In the 1950s Dr Spock, an American paediatrician, sold over 50 million 
copies in 42 countries of his best-selling book ‘Baby and Child Care’ in which he 
advised parents to place infants face-down in their cots. The advice was wrong and 
increased the risk of sudden infant cot death syndrome. Yet, evidence that 
positioning infants face down increases the risk of death was available in the 1970s. 
If the evidence had been assessed systematically at the time these risks might have 
been addressed sooner, but because no systematic review was available the risks 
went unrecognised and as a consequence an estimated 60,000 children died12. 
Also, differentiating between effective and ineffective interventions ensures that 
finite resources are not wasted funding ineffective drugs and surgical procedures13. 
Systematic reviews also assess the quality of the evidence, such as estimating 
whether the results are biased due to methodological weaknesses, and assessing 
the strength of the evidence by calculating how important the findings are in terms of 
benefits to patients, e.g. a reduction in risk of death compared with current 
practice14. Also, because all the available evidence has been compiled together, 
systematic reviews are useful in indicating if there are knowledge gaps that require 
further research15. 
 
Systematic reviews are also used to provide evidence outside of medicine, such as 
determining the effects of different social policies16, best educational practices17 and 
the effects of different custodial sentences18. Clinicians and policy makers often 
require a rapid appraisal of the clinical evidence to inform policy decisions, often due 
to political urgency. However, this need for rapid appraisal is at odds with the time 
needed to produce governmental commissioned Health Technology Assessments 
(HTA). These consist of a systematic review and economic cost-effectiveness 
evaluation and typically take 6 to 12 months to complete14,19. Not surprisingly, 
Cochrane systematic reviews are more protracted due in part to their reliance on 
academic volunteers and on average, require 23 months to complete20. In contrast 
with such urgency, systematic reviewing has steadily become more time-consuming 
due to the introduction of additional reporting steps to improve transparency such as 
(1) the Summary of Findings tables which provides key information concerning the 
quality of evidence and the magnitude of effect of the interventions, (2) the Risk of 
Bias assessment which is a 6 domain assessment of methodological biases, and (3) 
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the 27-item Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) checklist which is a minimum set of items for reporting in systematic 
reviews and meta-analyses.  
 
Some systematic reviews now incorporate more complex  indirect treatment 
comparisons using network meta-analysis21 which are more time-consuming. This 
enables networks of trials, which may not have been directly compared against each 
other, to be evaluated in the context of a network of inferences. Other complex and 
time-consuming strategies include the analysis of clinical study reports that are held 
by regulatory agencies22. Incorporating such data can hamper evaluation due to the 
practical, and administrative difficulties in obtaining these reports. Additionally, the 
reports are often provided as an image-based file which prevents use of free text 
searches and thus hampers data extraction. These developments have helped to 
improve the reliability of systematic reviews, but consequently have made the task 
of systematic reviewing more complex and time-consuming. 
 
1.3 Research growth  
The growth in published research23 has also been followed by the growth in 
published meta-analyses.  For example in 1995, 429 meta-analyses were published 
in PubMed, however, by 2011 that figure had increased to 473924. The scale of this 
problem facing the systematic review community is illustrated in Figure 2 which 
estimates the number of trials published from 1950 to 201023, and Figure 3 which 
estimates the number of systematic reviews published from 1990 to 201425.  
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Figure 2. The estimated number of published trials from 1950 to 2010. 
Source: Glasziou (2010) Evidence-Based Practice Workbook 
  
 
Figure 3. The estimated number of systematic reviews published from 1990 to 2014.  
Source: Kleijen (2017) Evaluation of NIHR investment in Cochrane infrastructure and 
systematic reviews. 
 
There are many barriers that researchers encounter whilst conducting a systematic 
review such as the phenomenon of multiple publishing of the same study data or 
‘Salami slicing’ as it has been termed26,27. The consequence of multiple publications 
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for reviewers is additional time needed to sift through multiple study reports to 
ensure that all belong to the same study and are not mistakenly counted as a new 
study.  Misidentifying multiple publications can lead to biased results and over-
estimate the treatment effect28. The problem faced by reviewers when encountering 
‘salami science’ can be considerable because subgroups are often reported so that 
numbers no longer match to the original study report and author names are re-
ordered or changed. For example, in one Cochrane review the authors uncovered 
over 140 separate reports relating to a single trial of olanzapine29. Often, in such 
circumstances the only possible means to ascertain provenance is to contact the 
authors for clarification. 
 
1.4 Updating systematic reviews 
Systematic reviews can quickly become out of date when newly published research 
emerges. To maintain relevance the Cochrane Collaboration used to advise that 
systematic reviews should either be updated within two years of the first published 
version, or the previous update14. However, it has been shown that only 20% of 
Cochrane reviews are updated within two years after publication30 leaving review 
groups struggling to remain relevant. There are several reasons for this, including 
availability of reviewers to commit time (much of the work is voluntary) and lack of 
financial resources. As a consequence, the original Cochrane policy of updating 
reviews regularly has been replaced with a policy based on prioritisation31. Non-
Cochrane systematic reviews are also affected by the increased methodological 
complexity, and are at risk of being out of date by the time of publication32. Also, 
non-Cochrane reviews represent the majority of systematic reviews published, and 
have the most to gain from automation technologies (Figure 4)25. Additional barriers 
that researchers have cited for not conducting or updating systematic reviews 
include lack of reviewer motivation, limited academic credit and limited publishing 
formats33. Therefore, there is an urgency to improve current research practices by 
developing better methods and applications to assist reviewers.   
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Figure 4 Percentage of all systematic reviews produced by Cochrane and other producers 
(total = 18,420; 2010-2015). 
Source: Kleijen (2017) Evaluation of NIHR investment in Cochrane infrastructure and 
systematic reviews. 
 
 
1.5 Current automation tools applied to systematic reviewing  
The development of automation tools has already begun, with reviewing software 
aimed at assisting systematic reviewers such as ExaCT34 that enable the reviewer 
to highlight relevant text such as the core components of a trial  known as the 
‘PICOS’ criteria (population, intervention, control, outcome, study design) which is 
the first step to ensure that the trial’s study design matches the inclusion criteria of 
the systematic review. This tool is a useful aid to spot key information more quickly, 
but is unable to extract and input the information into systematic reviewing software 
such as RevMan. RobotReviewer is a program that automatically assesses risk of 
bias in clinical trials35, and highlights the relevant text and extracts the information. It 
is an improvement on existing automated data extraction methods such as ExaCT, 
but is currently unable to equal the accuracy of a human screener. Web-based 
screening tools are now available such as Covidence36, DistillerSR37 and Rayyan38 
that visually enhance title and abstract screening by providing a user-friendly 
interface enabling the highlighting of subject specific keywords, automatically cross-
checking screening decisions between co-reviewers, and ranking records according 
to the probability of relevance. Ranking records assists with identifying relevant 
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studies earlier so that hard-copies can be acquired sooner for data extraction to 
reduce delays.  
 
These tools are under constant development and new features are being added 
based on feedback from users. Users have found many of the functions to greatly 
enhance collaborative review work by automatically cross-checking screening 
decisions, whilst other feature such as ranking trials by relevance have received 
mixed responses from reviewers with some users finding the feature unreliable. 
Such mixed reactions may be due to the complexity of different reviews and a 
thorough evaluation is needed to determine the accuracy of ranking records. Also, 
there are several automation tools offering similar functions and comparative 
evaluation is needed to determine the strengths and limitations of each product. 
Also, the development of toolkits39 which have been designed to adapt HTA reports 
from one context or country to another may have an emerging role in automating 
systematic reviews. For example, a toolkit enables users to decide if new work is 
required or if existing HTA reports on the same or similar topics can be adapted for 
their purposes by prompting a series of questions relating to the quality and 
relevance of existing reports using a variety of domains such as safety, 
effectiveness, and cost-effectiveness. There are many areas within systematic 
reviews that are inefficient and would benefit from automation and some of these 
areas may rely on semi-automation such as processes that require the input of 
human operators either to enable the machine to learn from prior decisions, or 
because the workflow of data may be hampered by incompatibilities. For example, 
transferring information contained in a relational database to a spreadsheet requires 
an operator to edit the data to enable the information to be recognised and 
displayed correctly. Some automation tasks will be less hampered by technical 
problems and more suited to fully automated processes, such as with statistical 
analysis and generation of forest plots. 
 
Expediting tasks that are time intensive for researchers, and therefore barriers to 
ensuring research remains relevant by the time of publication, are being explored 
with novel methods such as crowdsourcing.  This involves engaging with large 
numbers of volunteers who each contribute to a project that would otherwise have 
required a full-time research team to achieve. For example, the cataloguing and 
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coding of bibliographic database records in PubMed and EMBASE is too basic to 
enable precise identification of studies during biomedical database searching.  
Nonetheless, this problem can be overcome with volunteers brought together via the 
internet to enrich bibliographic records with additional coding (e.g. PICOS coding for 
types of Participants, Intervention, Comparator, Outcomes and Study design). One 
such project has already begun with the Cochrane Dementia Group40, whereby 
carers of people with dementia developed a specialist study-based register. 
 
Significant savings can be made by maximising retrieval of relevant records since 
searches closely match the inclusion and exclusion criteria, eliminate duplicate 
records, and avoid unwittingly re-screening the studies during an update review. 
Also, a study-based specialised register solves the problem of multiple publications 
or ‘salami science’ and the resulting confusion and extra work this creates since 
records are electronically linked to the original paper, and avoids creating extra work 
downstream for the reviewers.  For example, a study by the Cochrane Renal Group 
authors reported that in one review 56 reports were identified for just 14 trials41, and 
they estimated that tracking down and linking these further publications added at 
least an extra four months to completing their review. Without a study based register 
these problems are repeated for each new review title and its subsequent updates. 
Also, with a specialist register coding is only performed once for the original trial not 
for further reports. The current practice of updating a Cochrane review every two 
years ideally should be replaced with instant meta-analysis whereby meta-analysis 
is performed whenever a new trial is published. To achieve such an efficient model 
of production the current inefficiencies need to be addressed by adopting or 
developing methods from computer science. These problems have also recently 
been recognised in a (2017) UK Department of Health report25 which recommends 
that the Cochrane Collaboration “should work on developing expertise and 
processes to get better and quicker at producing reviews”. 
 
1.6 Summary 
Systematic reviewing has developed considerably both methodologically and 
organisationally since its inception in the 1970s. Its importance to the advancement 
of health research in recognised by both the research community and funding 
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bodies.  The growth in research has not been met by a growth in automation 
technologies and systematic review teams are unable to keep pace with the data 
influx. Better working practices are urgently needed that incorporate automation 
technologies to ensure that research findings remain relevant. Considerable gaps 
exist in the development and evaluation of automation technologies and to that aim 
this PhD is focussed on addressing those gaps in our current knowledge.    
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Chapter 2 
Research proposal 
The research aims of this PhD are to develop strategies to expedite the production 
of systematic reviews by developing and evaluating new methods to overcome the 
inefficiencies with current practices. Subsequently, four research projects (as shown 
in Figure 1) were conceived. The rationale for each research study was predicated 
upon several factors including personal knowledge of existing ‘bottle-necks’ that 
affect reviewers but which have not been previously investigated, or have not been 
fully developed. From this study 1 was conceived (Comparison of Biomedical 
Databases) which provided new insights into the scope and reliability of databases. 
Study 2 (Deduplication) was conceived, in part, due to the lack of progress shown 
by commercial software companies to advance current practices and therefore new 
methods were needed to overcome current limitations with deduplication. Study 3 
(Abstrackr predictive screening) was conceived to investigate the reliability of 
emerging technologies that are being applied to systematic reviews and that have 
the potential to save resources on tasks that are time-intensive. Study 4 (PICo 
based title-only citation screening) was conceived to develop new strategies to 
advance semi-automation by expediting screening using strategies that could either 
replace or complement current automation technologies. 
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2.1 A comparison of the performance of seven key bibliographic 
databases in identifying all relevant systematic reviews of 
interventions for hypertension 
 
Aim 
The aim of the study was to compare major bibliographic databases to determine 
which databases are best for identifying systematic reviews and how many 
databases need to be searched to identify all relevant records. The rationale for this 
study was the research gap in our understanding of how well databases performed 
specifically to identify systematic reviews and how many databases are needed to 
identify all information, including the reliability and comprehensiveness.  
 
Objectives: 
 
1.  Identify major bibliographic databases (MEDLINE, EMBASE, Cochrane library, 
     PubMed-Health, DARE, Epistemonikos, TRIP) that index systematic reviews. 
 
2. Develop search strategies for each database to identify systematic reviews of 
    intervention studies for the treatment of hypertension. 
 
3. Screen each database for relevant and irrelevant systematic reviews and 
    compare screening decisions between relational database to ensure consistency 
    with screening decisions. 
 
4. Evaluate the performance of each database to identify relevant studies using 
    sensitivity and precision. Using venn diagrams determine the number of 
    databases needed to be searched to identify all relevant systematic reviews  
    that were identified as relevant, i.e. the reference set.   
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2.2 Better duplicate detection for systematic reviewers: 
evaluation of systematic Review Assistant-Deduplication Module 
 
 
Aim  
The aim of the study was to develop methods to identify and remove duplicate 
records retrieved from biomedical database searches. The rationale for this study 
was predicated upon the poor performance of current practices. Existing methods of 
duplicate detection are unsatisfactory due to the poor performance, and therefore a 
new approach was needed to expedite duplicate detection and reduce workload by 
identifying duplicate citations with greater accuracy than the current method 
available in EndNote™ and similar bibliographic reference management software.   
 
 
Objectives:  
 
1) Evaluate the accuracy of the default auto-deduplication in EndNote™ against the 
    benchmark. 
 
2) Evaluate the accuracy of the new deduplication algorithm against the benchmark. 
 
3) Compare the accuracy of the new algorithm against the performance of  
     EndNote™ and calculate the sensitivity and specificity. 
 
4) Identify why records were wrongly classified (by algorithm), i.e. false positive and 
    false negative, and incorporate the findings into each iteration of the algorithm. 
 
5) Validate the accuracy of the final optimised algorithm using a series of different 
    datasets from intervention studies and screening tests, using different topic 
    specialities (cytology screening, stroke, and haematology). 
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2.3 Faster title and abstract screening? Evaluating Abstrackr, a 
semi-automated online screening program for systematic 
reviewers 
 
Aim 
The aim of the study was to evaluate the feasibility of using semi-automated 
screening methodologies to expedite title and abstract screening. The study was 
developed to address one of the current research gaps of limited validation of 
automation methods. 
 
Objectives: 
 
1.  Evaluate the recall accuracy of a semi-automated, machine learning citation 
     screening program - Abstrackr.  
 
2. Evaluate the workload saving of a semi-automated machine learning citation 
    screening program - Abstrackr. 
 
3. Perform sensitivity analyses on datasets with indistinct groups of participants.  
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2.4 PICo based title-only screening to expedite reviewing 
   
Aim 
The aim of this study was to develop and evaluate a new method to expedite the 
screening of study citations retrieved from biomedical database searches using a 
PICo based title-only screening method. The rationale for this study was the current 
unsatisfactory development with semi-automated citation screening applications 
which prompted the need to explore and develop an alternative method to reduce 
the workload with citation screening.  
  
Objectives: 
 
1. Survey the literature to obtain a sample of different datasets from previously 
    published systematic reviews to evaluate the screening methodology. 
 
2.  Develop keyword searching criteria and Boolean operators suitable for restrictive 
     title filed only searching. 
 
3.  Generate a list of search terms from the systematic reviews inclusion criteria 
     based upon the PICo criteria. Generate a list of synonyms for the PICo terms. 
 
4. Evaluate the screening results for recall against the included studies. Evaluate 
    the percentage reduction in screening effort.  
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Chapter 3 
Biomedical database coverage 
 
 
 
Key steps for conducting a systematic review and where studies for this PhD are focussed 
Formulate a question
Check question is not already answered 
Compare biomedical databases (study 1)
Develop Protocol
Pre‐state method (inclusion criteria, search strategy,
data extraction, outcomes, statistical analysis)
Search for studies 
Medline, EMBASE, Cochrane Central, grey literature, 
contact authors/manufacturers

Remove duplicate citations  (study 2)
Screen citations for relevance 
Abstrackr machine learning evaluation (study 3)
PICo based title‐only screening (study 4)
Data extraction

Quality Assessment & Data Analysis
Write report
Interpret and communicate findings to stakeholders
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In Chapter 1, the problem of the growth in published systematic reviews was 
highlighted. Prior to conducting a systematic review, it is necessary to determine 
whether the research question has been previously answered in an existing review, 
and thus avoiding wasteful replication of research. Answering this question requires 
a search of bibliographic databases, but this can be time-consuming because it is 
not known which biomedical database is the best to search. 
 
This question led to the development of a research study comparing seven 
biomedical databases to determine how many databases are necessary to identify 
all relevant systematic reviews on a given topic. This was the first published study 
that attempted to answer this question, as literature searches did not find equivalent 
or similar research. The research methods, data collection and analysis are 
described in this chapter and the findings discussed. 
 
Summary 
The published study demonstrated that no single database could identify all 
published systematic reviews on the topic of hypertension. This is due to the content 
and coverage of each database, but also the limitation of using systematic review 
search filters which can reduce the sensitivity of the search results. Nonetheless for 
this topic, EMBASE was the best performing database when assessed by sensitivity. 
The Cochrane library, which also indexes systematic reviews from other databases 
such as DARE and HTA, was the best performing when assessed according to 
specificity.  Regardless of which database is chosen, there is a trade-off between 
sensitivity and specificity and researchers need to choose which database is most 
appropriate. However, given the Cochrane library had the best specificity and was 
the second best performing database for sensitivity, researchers may be more likely 
to use this as the default option, before widening the search to include other 
databases. 
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3.1 A comparison of the performance of seven key bibliographic 
databases in identifying all relevant systematic reviews of 
interventions for hypertension 
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Abstract 
Background 
Bibliographic databases are the primary resource for identifying systematic reviews 
of healthcare interventions. Reliable retrieval of systematic reviews depends on the 
scope of indexing used by database providers. Therefore, searching one database 
may be insufficient, but it is unclear how many need to be searched. We sought to 
evaluate the performance of seven major bibliographic databases for the 
identification of systematic reviews for hypertension. 
Methods 
We searched seven databases (Cochrane library, Database of Abstracts of Reviews 
of Effects (DARE), Excerpta Medica Database (EMBASE), Epistemonikos, Medical 
Literature Analysis and Retrieval System Online (MEDLINE), PubMed Health and 
Turning Research Into Practice (TRIP)) from 2003 to 2015 for systematic reviews of 
any intervention for hypertension. Citations retrieved were screened for relevance, 
coded and checked for screening consistency using a fuzzy text matching query. 
The performance of each database was assessed by calculating its sensitivity, 
precision, the number of missed reviews and the number of unique records retrieved. 
Results 
Four hundred systematic reviews were identified for inclusion from 11,381 citations 
retrieved from seven databases. No single database identified all the retrieved 
systematic reviews for hypertension. EMBASE identified the most reviews 
(sensitivity 69 %) but also retrieved the most irrelevant citations with 7.2 % precision 
(Pr). The sensitivity of the Cochrane library was 60 %, DARE 57 %, MEDLINE 57 %, 
PubMed Health 53 %, Epistemonikos 49 % and TRIP 33 %. EMBASE contained the 
highest number of unique records (n = 43). The Cochrane library identified seven 
unique records and had the highest precision (Pr = 30 %), followed by 
Epistemonikos (n = 2, Pr = 19 %). No unique records were found in PubMed Health 
(Pr = 24 %) DARE (Pr = 21 %), TRIP (Pr = 10 %) or MEDLINE (Pr = 10 %). 
Searching EMBASE and the Cochrane library identified 88 % of all systematic 
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reviews in the reference set, and searching the freely available databases 
(Cochrane, Epistemonikos, MEDLINE) identified 83 % of all the reviews. 
The databases were re-analysed after systematic reviews of non-conventional 
interventions (e.g. yoga, acupuncture, exercise) were removed. Similarly, no 
database identified all the retrieved systematic reviews. EMBASE identified the most 
relevant systematic reviews (sensitivity 73 %) but also retrieved the most irrelevant 
citations with Pr = 5 %. The sensitivity of the Cochrane database was 62 %, followed 
by MEDLINE (60 %), DARE (55 %), PubMed Health (54 %), Epistemonikos (50 %) 
and TRIP (31 %). The precision of the Cochrane library was the highest (20 %), 
followed by PubMed Health (Pr = 16 %), DARE (Pr = 13 %), Epistemonikos 
(Pr = 12 %), MEDLINE (Pr = 6 %), TRIP (Pr = 6 %) and EMBASE (Pr = 5 %). 
EMBASE contained the most unique records (n = 34). The Cochrane library 
identified seven unique records. The other databases held no unique records. 
Conclusions 
The coverage of bibliographic databases varies considerably due to differences in 
their scope and content. Researchers wishing to identify systematic reviews should 
not rely on one database but search multiple databases. 
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Introduction 
Systematic reviews provide the best evidence of the effects of healthcare 
interventions [1]. However, identifying systematic reviews can be time-consuming 
and haphazard because no database covers all health topics [2]. Therefore, 
searching several databases is a necessity when seeking health research, including 
systematic reviews. With the growth [3] and scatter of research [4], finding relevant 
and up-to-date information is becoming increasingly difficult. Moreover, clinicians 
who perform quick clinical queries with one database often lack the training and 
skills to run efficient searches and subsequently produce imprecise results [5]. 
Understandably, there is currently no specific guidance on which databases should 
be searched to find systematic reviews, only general advice to search widely. For 
example, researchers planning a systematic review are recommended to first 
search for existing reviews which answer the research question to avoid duplicating 
research [6], but it is unclear which is the best database to search or how many 
should be searched. 
The aim of this study was to evaluate seven databases—the Cochrane library, the 
Database of Abstracts of Reviews of Effects (DARE), Excerpta Medica Database 
(EMBASE), Epistemonikos, Medical Literature Analysis and Retrieval System 
Online (MEDLINE), PubMed Health and Turning Research Into Practice (TRIP) to 
determine their coverage of systematic reviews assessing effectiveness of 
interventions of a typical high-prevalence condition, hypertension, and to determine 
how many databases require searching to identify all relevant systematic reviews. 
Methods 
We searched seven databases (EMBASE, MEDLINE, the Cochrane library (inc. 
CDSR, DARE and HTA), Epistemonikos, PubMed Health, DARE and TRIP) for 
systematic reviews of any treatment interventions for hypertension from 2003 to Jan 
2015 (see Fig. 1). The databases were chosen because of their prominence as 
research databases that index systematic reviews.  We used an open definition of 
systematic review which included reviews stated or described as being a systematic 
review or meta-analysis. Reports and summaries of evidence were excluded. PICO 
criteria were defined as follows: participants, i.e. people with hypertension by any 
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definition; interventions, any; comparator, any; and outcomes, change in blood 
pressure. Systematic review filterers incorporated into the databases were selected 
to increase search sensitivity. For MEDLINE, we used the Montori filter [7]. Citations 
retrieved were imported into separate EndNote™ X7 libraries, and then titles and 
abstracts were screened for relevance by one reviewer. Reviews of pre-
hypertension, ophthalmic, pulmonary, pregnancy-related hypertension or hepatic 
hypertension were excluded. Greasemonkey scripts were used to assist with the 
retrieval of the contents of web pages which did not have full citation download 
options (see supplementary appendix A). 
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Fig. 1 Search strategies 
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Citations were coded in EndNote™ X7 as either a systematic review or not. 
Screening decisions in one database were cross-checked against the other six 
databases to ensure consistency using a title-matching database query. The query 
incorporated a fuzzy text matching algorithm [8, 9] to account for differences with 
punctuation or syntax errors. Where screening decisions were found to be 
inconsistent, these were re-examined and standardised across the databases. 
Where databases (e.g. PubMed Health) used the Cochrane plain language title 
rather than the original full title, these were changed to the full title for consistency 
with other databases*. 
 
Data analysis 
The performance of each database was assessed by calculating the sensitivity 
(number of relevant studies/reference set × 100); the precision (number of relevant 
studies/number of studies retrieved × 100); the number missed (reference set − 
number of relevant studies); and the number of unique records, i.e. records only 
found in one database. The reference set is the total of unique systematic reviews 
identified across all the databases. Records identified as being unique were double-
checked for accuracy using a title search within the (online) comparator 
bibliographic databases without the systematic review search filters applied. A 
secondary analysis was performed by removing all non-conventional treatments, i.e. 
systematic reviews that are not prescribed drugs, e.g. yoga, acupuncture, herbal 
medicine, and exercise programmes, from the databases and re-calculated to 
provide results reflecting the type of quick clinical queries clinicians would run. 
 
 
 
 
____________________________________________________________ 
 
*For additional methodological details see Supplementary appendix A 
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Results 
There were 400 systematic reviews (the reference set) identified for inclusion from a 
total of 11,381 citations retrieved from seven databases. No database identified all 
400 included systematic reviews of interventions for hypertension (Table 1). 
EMBASE retrieved the highest number of relevant reviews (n = 276) with a 
sensitivity (s) of 69.0 %, followed by Cochrane (n = 240, s = 60.0 %), DARE (n = 228, 
s = 57.0 %), MEDLINE (n = 228, s = 57.0 %), PubMed Health (n = 212, s = 53.0 %), 
Epistemonikos (n = 195, s = 48.8 %) and TRIP (n = 131, s = 32.8 %). EMBASE 
contained the largest number of unique records (n = 43) but had the lowest precision 
(Pr, 7.2 %). Cochrane contained seven unique records and had the highest 
precision (29.9 %), followed by Epistemonikos (n = 2, Pr = 19.2 %). No unique 
records were found in PubMed Health (Pr = 23.6 %), DARE (Pr = 20.8 %), TRIP 
(Pr = 9.7 %) or MEDLINE (Pr = 9.6 %). Searching the two databases with the highest 
sensitivity and unique records (EMBASE and the Cochrane library) identified 88 % 
of the reference set (Fig. 2). Searching the Cochrane library, MEDLINE and 
Epistemonikos identified 83 % of the reference set (Fig. 3). 
 
Table 1 Performance of bibliographic databases identifying relevant systematic 
reviews of interventions for treating hypertension 
Database Reviews relevant 
Reviews 
missed 
Total 
citations
Sensitivity 
(s) % 
Precision 
(Pr) % 
Unique 
records 
EMBASE 276 124 3836 69.0 7.2 43 
Cochrane 240 160 802 60.0 29.9 7 
DARE 228 172 1098 57.0 20.8 0 
MEDLINE 228 172 2374 57.0 9.6 0 
PubMed 
Health 212 188 899 53.0 23.6 0 
Epistemonikos 195 205 1017 48.8 19.2 2 
TRIP 131 269 1355 32.8 9.7 0 
Reference set of included systematic review (n = 400) 
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Fig. 2 Proportion of reference set (n = 400) retrieved by searching EMBASE and the 
Cochrane library, resulting in the identification of 88 % (n = 352) of total reviews 
 
 
 
Fig. 3 Proportion of reference set (n = 400) retrieved by searching Cochrane, 
Epistemonikos and MEDLINE, resulting in the identification of 83 % (n = 330) of total 
reviews 
 
After removing 168 non-conventional medical interventions for hypertension, e.g. 
yoga, acupuncture, herbal medicine, and exercise programmes, there were 232 
systematic reviews remaining in the reference set. Again, no database identified all 
included systematic reviews of conventional interventions for hypertension (Table 2). 
EMBASE retrieved the highest number of relevant records (n = 169) with a 
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sensitivity of 72.8 %, followed by the Cochrane library (n = 143, s = 61.6 %), 
MEDLINE (n = 138, s = 59.5 %), DARE (n = 127, s = 54.7 %), PubMed Health 
(n = 126, s = 54.3 %), Epistemonikos (n = 116, s = 50.0 %) and TRIP (n = 72, 
s = 31.0 %). EMBASE contained the largest number of unique records (n = 34) but 
had the lowest precision (Pr = 4.5 %). Cochrane contained seven unique records 
and had the highest precision (Pr = 20.3 %). No unique records were found in 
PubMed Health (Pr = 15.5 %), DARE (Pr = 12.7 %), Epistemonikos (Pr = 12.4 %), 
MEDLINE (Pr = 6.0 %) or TRIP (Pr = 5.5 %). 
 
Table 2 Performance of bibliographic databases identifying relevant systematic 
reviews of interventions for treating hypertension (excluding non-conventional 
treatments) 
Database Reviews relevant 
Reviews 
missed 
Total 
citations
Sensitivity 
(s) % 
Precision 
(Pr) % 
Unique 
records 
EMBASE 169 63 3722 72.8 4.5 34 
Cochrane 143 89 704 61.6 20.3 7 
MEDLINE 138 94 2282 59.5 6.0 0 
DARE 127 105 998 54.7 12.7 0 
PubMed 
Health 126 106 812 54.3 15.5 0 
Epistemonikos 116 116 938 50.0 12.4 0 
TRIP 72 160 1320 31.0 5.5 0 
Reference set of included systematic review (n = 232) 
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Discussion 
Seven databases were searched—the Cochrane library, DARE, EMBASE, 
Epistemonikos, MEDLINE, PubMed Health and TRIP—to determine their coverage 
of systematic reviews of interventions for hypertension. No single database retrieved 
the entire reference set of 400 reviews; EMBASE had the highest sensitivity of 69 % 
but would still miss 124 reviews. Searching both the Cochrane library and EMBASE 
identified 88 % of the reference set. EMBASE, however, is a subscription service 
and many institutions do not subscribe to EMBASE, which may limit some clinicians 
from performing clinical queries. Nevertheless, in the example used in this study, 
searching the Cochrane library, MEDLINE and Epistemonikos retrieves 83 % of the 
reference set. 
Our findings have illustrated that despite the broad scope of many bibliographic 
databases, relying on one or two to identify a systematic review is not always 
possible, and wider search should be considered to ensure systematic reviews are 
not missed. 
Strengths and limitations  
We used systematic review filters to increase precision during the search for 
hypertension reviews, which can reduce the sensitivity. Therefore, records classed 
as unique were cross-checked with the comparator databases by searching in title 
fields without applying the filter to ensure the record was genuinely unique rather 
than missed due to filtering. However, this procedure was not performed where 
systematic reviews were found in two or more databases, and therefore, some 
reviews may have been missed due to use of filters or the reviews being 
inadequately coded in the databases. However, reduced sensitivity will have 
affected all databases since filters were applied universally. Discarding search filters, 
however, is impractical due to the large number of records that would be retrieved. 
Screening was performed by one reviewer with the potential for screening errors 
between databases; therefore, to ensure screening decisions were consistent, a 
fuzzy text matching query [10] was used. Our case study did not include every 
bibliographic database available, but we included seven major databases, including 
the two largest (EMBASE and MEDLINE); however, the results may not be 
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applicable to specialist databases if they are not indexed in MEDLINE, EMBASE or 
the Cochrane library. Our focus was limited to one clinical condition (hypertension), 
but other clinical topics are also likely to be dispersed throughout these databases 
without a single database containing all records. Other study designs such as 
prognostic and diagnostic studies were not evaluated, and database searches for 
this type of study design may perform differently. The DARE database provided a 
search platform with good overall sensitivity and precision, but funding for DARE 
ceased at the end of March 2015 ([11]), and as it is no longer being updated, this 
database will increasingly become less sensitive for identifying systematic reviews. 
 
Conclusions 
This case study demonstrated that relying on a single database is insufficient to 
identify all relevant systematic reviews. Depending on the database used, the 
chances of finding the proportion of relevant reviews ranged from 33 to 69 %, and 
therefore, searching should not be restricted to two major databases; instead, a 
search of additional databases should be performed to determine if a review title 
exists. Further research is warranted to assess how these findings might extend to 
other topic areas and study designs. 
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Chapter 4  
Duplicate detection within bibliographic records 
 
 
Key steps for conducting a systematic review and where studies for this PhD are focussed 
Formulate a question
Check question is not already answered 
Compare biomedical databases (study 1)
Develop Protocol
Pre‐state method (inclusion criteria, search strategy, data extraction, 
outcomes, statistical analysis)
Search for studies 
Medline, EMBASE, Cochrane Central, grey literature,
contact authors/manufacturers

Remove duplicate citations  (study 2)
Screen citations for relevance
Abstrackr machine learning evaluation (study 3)
PICo based title‐only screening (study 4)
Data extraction

Quality Assessment & Data Analysis
Write report
Interpret and communicate findings to stakeholders
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In Chapter 3, the problems of relying on a single database to identify systematic 
reviews was highlighted. Even searching several databases is no guarantee that all 
published reviews are identified, due in part to differences in the scope of each 
database provider, sensitivity of systematic review filters, technical errors with plain 
language summaries being used in place of the original title, and technical problems 
with databases. The most reliable database (EMBASE) was also the least precise, 
requiring thousands of records to be screened. Due to the overlapping content of 
different biomedical databases, duplicate records are inevitably retrieved during 
searches for both systematic reviews and randomised controlled trials (as 
highlighted in Chapter 1). From this problem arose the question: How can the 
identification and removal of duplicate records from bibliographic databases be 
improved? 
 
In Chapter 4 the research undertaken to identify duplicate records more effectively 
is described. Four deduplication algorithms were developed and modified by 
incorporating the findings from each version. To test the performance of an 
algorithm, a ‘gold standard’ reference set of citations, from a published systematic 
review, was created by coding citations as either a unique or duplicate record. Each 
algorithm and the auto-deduplication facility in EndNote™ were tested against the 
reference set. Following this iterative process of testing and developing the 
algorithms, the best performing algorithm was selected for validation testing using 
datasets from three systematic reviews to determine if the initial findings were 
replicable. The implications for this new method of duplicate detection within the 
research community are discussed and recommendations are provided for 
additional research to further improve duplicate detection.  
 
Summary 
This study was published on 14th January 201542 and has subsequently been cited 
15 times. The detection of duplicate records by the new algorithm was greater than 
EndNote™, achieving both higher sensitivity and specificity. The algorithm is being 
used at the Centre for Research in Evidence-Based Practice (CREBP), and 
following the publication of this study, the deduplication application has been made 
available to other academic researchers and information specialists through the 
CREBP web page. Interest in the algorithm from research groups is growing 
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following the study’s publication. Links with the Melbourne Cochrane group have 
been established with the aim of collaborating with the development of automation 
tools, including incorporating the deduplication tool into their existing Covidence 
screening software36. The Cochrane Collaboration has also expressed interest as 
currently their deduplication tool is based upon the deduplication algorithm used in 
EndNote™. The deduplication research was further disseminated with a 
presentation at The European Public Health conference in Milan, Italy in 2015 and 
received interest from participants active in public health research. A revised second 
version is planned that will enable users to pre-select the degree of sensitivity and 
specificity according to their needs. 
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Abstract 
Background 
A major problem arising from searching across bibliographic databases is the 
retrieval of duplicate citations. Removing such duplicates is an essential task to 
ensure systematic reviewers do not waste time screening the same citation multiple 
times. Although reference management software use algorithms to remove 
duplicate records, this is only partially successful and necessitates removing the 
remaining duplicates manually. This time-consuming task leads to wasted resources. 
We sought to evaluate the effectiveness of a newly developed deduplication 
program against EndNote™. 
 
Background 
A literature search of 1,988 citations was manually inspected and duplicate citations 
identified and coded to create a benchmark dataset. The Systematic Review 
Assistant-Deduplication Module (SRA-DM) was iteratively developed and tested 
using the benchmark dataset and compared with EndNote’s default one step auto-
deduplication process matching on (‘author’, ‘year’, ‘title’). The accuracy of 
deduplication was reported by calculating the sensitivity and specificity. Further 
validation tests, with three additional benchmarked literature searches comprising a 
total of 4,563 citations were performed to determine the reliability of the SRA-DM 
algorithm. 
 
Results 
The sensitivity (84%) and specificity (100%) of the SRA-DM was superior to 
EndNote™ (sensitivity 51%, specificity 99.83%). Validation testing on three 
additional biomedical literature searches demonstrated that SRA-DM consistently 
achieved higher sensitivity than EndNote™ (90% vs 63%), (84% vs 73%) and (84% 
vs 64%). Furthermore, the specificity of SRA-DM was 100%, whereas the specificity 
of EndNote™ was imperfect (average 99.75%) with some unique records wrongly 
assigned as duplicates. Overall, there was a 43% relative increase in the number of 
duplicates records detected with SRA-DM compared with EndNote™ auto-
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deduplication. 
 
Conclusions 
The Systematic Review Assistant-Deduplication Module offers users a reliable 
program to remove duplicate records with greater sensitivity and specificity than 
EndNote™. This application will save researchers and information specialists time 
and avoid research waste. The deduplication program is freely available online. 
  
Background 
Identifying trials for systematic reviews is time consuming: the average retrieval from 
a PubMed search produces 17,284 citations [1]. The biomedical databases 
MEDLINE[2] and EMBASE[3] contain over 41 million records, and about one million 
records are added annually to EMBASE[3] (which now also includes MEDLINE 
records) and 700,000 to MEDLINE[2]. However, the methodological details of trials 
are often inadequately described by authors in the titles or abstracts, and not all 
records contain an abstract [4]. Due to these limitations, a wider (that is, more 
sensitive) search strategy is necessary to ensure articles are not missed, which 
leads to an imprecise dataset retrieved from electronic bibliographic databases. 
Typically, of the thousands of citations retrieved for a systematic review search over 
90% are excluded on the basis of title and abstract screening [5]. 
 
Searching multiple databases is essential because different databases contain 
different records, and therefore, the coverage is widened. Also, searching multiple 
databases utilises differences in indexing to increase the likelihood of retrieving 
relevant items that are listed in several databases [6], but inevitably, this practice 
also retrieves overlapping content [7]. The degree of journal overlap estimated by 
Smith [8] over a decade ago indicated that about 35% of journals were listed in both 
MEDLINE and EMBASE. Journal overlap can vary from 10% to 75% [8,9,10,11,12] 
depending on medical speciality. More recently, the overlap in MEDLINE and 
EMBASE was found to be 79% [13] based on trials that had been included in 66 
Cochrane systematic reviews. 
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The problem of overlapping content and subsequent retrieval of duplicate records is 
partially managed with commercial reference management software programs such 
as EndNote™[14], Reference Manager[15], Mendeley[16] and RefWorks[17]. They 
contain algorithms designed to identify and remove duplicate records using an auto-
deduplication function. However, the detection of duplicate records can be thwarted 
by inconsistent citation details, missing information, or errors in the records. 
Typically, auto-deduplication is only partially successful [18], and the onerous task 
of manually sifting and removing the remaining duplicates rests with reviewers or 
information specialists. Removing such duplicates is an essential task to ensure 
systematic reviewers do not waste time screening the same citation multiple times. 
This study aimed to iteratively develop and test the performance of a new 
deduplication program against EndNote™ X6. 
 
Methods 
Systematic Review Assistant-Deduplication Module process of development 
The Systematic Review Assistant-Deduplication Module (SRA-DM) project was 
developed in 2013 at the Bond University Centre for Research in Evidence-Based 
Practice (CREBP). The project aimed to reduce the amount of time taken to produce 
systematic reviews by maximising the efficiency of the various review stages such 
as optimising search strategies and screening, finding full text articles and removing 
duplicate citations. 
 
The deduplication algorithm was developed using a heuristic-based approach with 
the aim of increasing the retrieval of duplicate records and minimising unique 
records being erroneously designated as duplicates. The algorithm was developed 
iteratively with each version tested against a benchmark dataset of 1,988 citations. 
Modifications were made to the algorithm to overcome errors in duplicate detection 
(Table 1). For example, errors often occurred due to variations in author names (e.g. 
first-name/surname sequence, use/absence of initialisation, missing author names 
and typographical errors), page numbers (e.g. full/truncated, or missing), text accent 
marks (e.g. French/German/Spanish) and journal names (e.g. abbreviated/complete, 
and ‘the’ used intermittently). The performance of the SRA-DM algorithm was 
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compared with EndNote’s default one step auto-deduplication process. To 
determine the reliability of SRA-DM, we conducted a series of validation tests with 
results of different literature searches (cytology screening tests, stroke and 
haematology) which were retrieved from searching multiple biomedical databases 
(Table 2). 
 
 
Table 1. SRA-DM algorithm changes  
Iterations Changes to algorithms 
First 
iteration 
Matching criteria were based on simple field comparison (ignoring punctuation) 
with checks against the year field since this field has a lower probability for 
errors because it is restricted to integers 0–9 and therefore the best non-
mistakable field. 
Second 
iteration 
Short format page numbers were converted to full format (e.g. 221–226, 221–
6), and the algorithm was further modified to increase the sensitivity by 
incorporating matching criteria on authors OR title. 
Third 
iteration 
Match author AND title with the extension of the non-reference fields from only 
‘year’ to year OR volume OR edition. 
Fourth 
iteration 
The fourth algorithm extended the matching criteria of the third algorithm, with 
the addition of an improved name matching system. This was context aware of 
author name variations, i.e. initialisation, punctuation and rearranged author 
listings using fuzzy logic, so that differences could be accommodated. For 
example, the following names are all syntactically equivalent and will match as 
identical authors: 
1. William Shakespeare 
2. W. Shakespeare 
3. W Shakespeare
4. William John Shakespeare 
5. William J. Shakespeare 
6. W. J. Shakespeare 
7. W J Shakespeare 
8. Shakespeare, William 
9. Shakespeare, W 
10. Shakespeare, W, A 
11. Shakespeare, W, A, B, C 
12. William Shakespeare 1st 
13. William Shakespeare 2nd 
14. William Shakespeare IV
15. William Adam Bob Charles Shakespeare XVI 
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Table 2 Databases searched for retrieval of citations for validation testing  
Datasets Databases searched
Cytology screening tests 1. Cochrane Controlled Trials Register (CCTR) 
  2. Cochrane Database of Systematic Reviews (CDSR) 
  3. EMBASE 
  4. MEDLINE 
  5. National Research Register (NRR) 
  6. Database of Assessments of Reviews of Effectiveness 
  7. NHS Health Technology Assessment (HTA) 
  8. PreMEDLINE 
  9. Science Citation Index 
  10. Social Sciences Citation Index 
Haematology dataset  1. MEDLINE 
  2. EMBASE 
  3. MEDLINE In-Process 
  4. Biological Abstracts 
  5. NHS Health Technology Assessment (HTA) 
  6. Cochrane Controlled Trials Register (CCTR) 
  7. Cochrane Database of Systematic Reviews (CDSR) 
  8. CINAHL 
  9. Science Citation Index 
  10. Social Sciences Citation Index 
Stroke dataset  1. MEDLINE 
  2. EMBASE 
  3. CENTRAL 
  4. CINAHL 
  5. PsycInfo 
 
Definitions 
A duplicate record was defined as being the same bibliographic record (irrespective 
of how the citation details were reported, e.g. variations in page numbers, author 
details, accents used or abridged titles). Where further reports from a single study 
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were published, these were not classed as duplicates as they are multiple reports 
which can appear across or within journals. Similarly, where the same study was 
reported in both journal and conference proceedings, these were treated as 
separate bibliographic records. 
 
Testing against benchmark* 
A total of 1,988 citations, derived from a search conducted on 29 July 2013 for 
surgical and non-surgical management for pleural empyema were used to test SRA-
DM and EndNote™ X6. Six databases were searched (MEDLINE-Ovid, EMBASE-
Elsevier, CENTRAL-Cochrane library, CINAHL-Ebasco, LILACS-Bireme, PubMed-
NLM). To create the benchmark, citations were imported into EndNote™ database, 
sorted by author, inspected for duplicate records and manually coded as a unique or 
duplicate record; the database was reordered by article title and reinspected for 
further duplicates. Once the benchmark was finalised, duplicates were sought in 
EndNote™ using the default one-step auto-deduplication process which used the 
matching criteria of ‘author’, ‘year’ and ‘title’ (with the ‘ignore spacing and 
punctuation’ box ticked). A few additional duplicates were identified in EndNote™ 
and SRA-DM whilst cross-checking against the benchmark decisions, and the 
benchmark and results were updated to take account of these. 
 
Data analysis 
The accuracy of the results were coded against the benchmark according to 
whether it was a true positive (true duplicate, i.e. correctly identified duplicate), false 
positive (false duplicate, i.e. incorrectly identified as duplicate), true negative (unique 
record) or false negative (true duplicate, i.e. incorrectly identified as unique record). 
This process was repeated for results received after using the SRA-DM. Sensitivity 
is defined as the ability to correctly classify a record as duplicate and is the 
proportion of true positive records over the total number of records identified as true 
positive and false negative. Specificity is defined as the ability to correctly classify a 
record as being unique or non-duplicate and is the proportion of true negative 
records over the total number of records identified as true negative and false 
positive. 
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*For additional methodological details see Supplementary appendix B 
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Results 
Training and development of SRA-DM 
First and second iteration 
The first iteration of the deduplication algorithm achieved 75.0% sensitivity and 99.9% 
specificity (Table 3). The matching criteria were based on field comparison (ignoring 
punctuation) with checks made against the year field. This field was chosen 
because the year field has a lower probability for errors since it is restricted to 
integers 0–9 and therefore is the best non-mistakable field. Eighty-four percent of 
undetected duplicates arose due to variations in page numbers (e.g. 221–226, 221–
6). To address this, short format page numbers were converted to full format and 
the algorithm was further modified to increase the sensitivity by incorporating 
matching criteria on authors OR title. This increased the sensitivity of the second 
iteration to 95.7% with more duplicates detected, but as a consequence the number 
of false positives also increased (specificity 99.8%). 
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Table 3  
Sensitivity† and specificity‡ of SRA-DM prototype algorithms and EndNote 
auto-deduplication (in a dataset of 1,988 citations, including 799 duplicates)  
 
   Respiratory study 
First 
iteration 
SRA-DM 
Second 
iteration 
SRA-DM 
Third 
iteration 
SRA-DM 
Fourth 
iteration 
SRA-DM 
EndNote
True positive (n) 
(correctly identified 
duplicates) 
600 765 543 674 410
False negative (n) 
(duplicates missed) 
199 34 256 125 391
Sensitivity (%) 75.1 95.7 68.0 84.4  51.2
True negative (n) 
(correctly identified 
unique records) 
1,188 1,186 1,189 1,189 1,185
False positive (n) 
(incorrectly identified 
as duplicates) 
1 3 0 0 2
Specificity (%) 99.9 99.8 100.0 100.0  99.8 
  
 
 
Third iteration 
The third iteration was modified to match author AND title with the extension of the 
non-reference fields from only ‘year’ to year OR volume OR edition. This 
distinguished the references that were similar (e.g. same author and title 
combination) but contained different source publications, and this improved the 
specificity to 100% but the sensitivity was reduced (68.0%). 
 
Fourth iteration 
The fourth iteration was modified to accommodate author name variations using 
fuzzy logic so that differences in names spelt in full or initialised, differences in the 
number of true positive results †Sensitivity  ;
number of true positives + number of false negatives
number of true negatives ‡Specificity
number of true negatives + number of false positives 

 
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ordering of name and different punctuation could be accommodated (Table 1); this 
increased the sensitivity to 84.4% by correctly identifying 674 citations as duplicates 
(TP), 1,189 citations as unique records (TN), no false positives occurred (100% 
specificity) and only 125 duplicate records were undetected (FN). This fourth 
iteration of SRA-DM was then compared against EndNote™. EndNote™ identified 
412 of the 1,988 citations as duplicates. Of these, 410 were correctly identified as 
duplicates (TP) and two were incorrectly designated as duplicates (FP), and 1,185 
citations were correctly identified as unique records (TN) and 391 duplicate citations 
were undetected (FN). The sensitivity of EndNote™ was 51.2% and specificity 
99.8%. Compared with EndNote™, SRA-DM produced a 64% increase in sensitivity 
and no loss of specificity. 
 
Validation results 
The fourth iteration of SRA-DM was further tested with three additional datasets 
using search topics from cytology screening tests (n = 1,856), stroke (n = 1,292) and 
haematology (n = 1,415) (Table 2). These were obtained from existing searches 
performed by information specialists to widen the scope of the validation tests. SRA-
DM algorithm was consistently more sensitive (Table 4) at detecting duplicates than 
EndNote™ [cytology screening: 90% vs 63%; stroke: 84% vs 73% and haematology: 
84% vs 64%] and specificity of SRA-DM was 100% accurate, i.e. no false positives 
occurred. In contrast, the average specificity of EndNote™ was lower (99.7). These 
false positives occurred in EndNote™ due to citations with the same authors and 
title being published in other journals or as conference proceeding. Compared with 
EndNote™, the average percentage increase in duplicates detected by SRA-DM 
across all four bibliographic searches was 42.8%. 
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Table 4  
Sensitivity† and specificity‡ of SRA-DM and EndNote auto-deduplication 
(validation testing)  
  Cytology 
screening 
Stroke Haematology 
SRA-DM EndNote SRA-
DM 
EndNote SRA-
DM 
EndNote
True positive (correctly 
identified duplicates) 
1,265 885 426 372 208 159
False negative  
(duplicates missed) 
139 518 81 134 38 87
Sensitivity (%) 90.10 63.08 84.02 73.52  84.55  64.63 
True negative (correctly 
identified unique records) 
452 452 785 784 1,169 1,165
False positive (incorrectly 
identified duplicates) 
0 1 0 2 0 4
Specificity (%) 100.00 99.78 100.00 99.75  100.00  99.66
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Discussion 
Our findings demonstrated that SRA-DM identifies substantially more duplicate 
citations than EndNote™ and has greater sensitivity [(84% vs 51%), (90% vs 63%), 
(84% vs 73%), (84 vs 64%)]. The specificity of SRA-DM was 100% with no false 
positives, whereas the specificity of EndNote™ was imperfect. 
 
Waste in research occurs for several methodological, legislative and reporting 
reasons [19, 20, 21, 22]. Another form of waste is inefficient labouring, in part, 
because of non-standardised citations details across bibliographic databases, 
perfunctory error checking and absence of a unique trial identification number for it 
and its associated further multiple reports. If these issues were solved at source, 
manual duplicate checking would be unnecessary. Until these issues are resolved, 
deploying the SRA-DM will save information specialists and reviewers valuable time 
by identifying on average a further 43% of duplicate records. 
 
Several citations were wrongly designated as duplicates by EndNote™ auto-
deduplication due to different citations sharing the same authors and title but 
published in other journals or as conference proceedings. In a recent study by Jiang 
[23], the authors also found that EndNote™, for the same reason, had erroneously 
assigned unique records as duplicates. It is probable that in most scenarios no 
important loss of data would occur; although sometimes additional methodological 
or outcome data are reported, and ideally these need to be retained for inspection. 
A recent study by Qi [18] examined the content of undetected duplicate records in 
EndNote™ and found that errors often occurred due to missing or wrong data in the 
fields, especially for records retrieved from EMBASE database. This also affected 
the sensitivity of SRA-DM, with duplicates undetected due to missing or wrong or 
extraneous data in the fields. 
 
During the training and development stage, the four iterations of SRA-DM achieved 
sensitivities ranging from 68%, 75%, 84% and 96% with the most sensitive (96%) 
achieved with a trade-off in specificity (99.75%) with three false positives. For 
systematic reviews and Health Technology Assessment reports, the aim is to 
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conduct comprehensive searches to ensure all relevant trials are identified [24]; thus, 
losing even three citations is undesirable. Therefore, the final algorithm (fourth 
iteration) with the lower sensitivity (84%) but perfect (100%) specificity was 
preferred. Future developments with SRA-DM may incorporate two algorithms, first 
using the 100% specific algorithm to automatically remove duplicates and another 
algorithm with higher sensitivity (albeit with lower specificity) to identify the 
remaining duplicates for manual verification. If this strategy was implemented on the 
respiratory dataset using the fourth and second algorithm (Table 3), only 91 out of 
1,988 citations would have to be manually checked and only 34 duplicates would 
remain undetected. 
 
In spite of this major improvement with the SRA-DM, no software can currently 
detect all duplicate records, and the perfect uncluttered dataset remains elusive. 
Undetected duplicates in SRA-DM occurred due to discrepancies such as missing 
page numbers or too much variance with author names. Duplicates were also 
missed because the OVID MEDLINE platform inserted additional extraneous 
information into the title field (e.g. [Review] [72 refs]) whereas the same article 
retrieved from EMBASE or other non-OVID MEDLINE platforms (i.e. PubMed, Web 
of Knowledge) report only the title. Some of these problems could be overcome in 
the future with record linkage and citation enrichment techniques to populate blank 
fields with meta-data to increase the detection rate. 
 
Strengths and weaknesses 
The deduplication program was developed to identify duplicate citations from 
biomedical databases and has not been tested on other bibliographic records such 
as books and governmental reports and therefore may not perform as well with 
other bibliographies. However, the deduplication program was developed iteratively 
to remove problems of false positives and was tested on four different datasets 
which included comprehensive searches using 14 different databases that are used 
by information specialists, and therefore, similar efficiencies should occur in other 
medical specialities. Also, the accuracy of SRA-DM was consistently higher than 
that of EndNote™, and these finding are probably generalizable to other biomedical 
database searches due to the same records types and fields used. It is possible that 
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some duplicates were not detected during the manual benchmarking process, 
although the database was screened twice first by author and then by title, and 
additional cross-checking was performed by manually comparing the benchmark 
against EndNote™ auto-deduplication and SRA-DM decisions—thus minimising the 
possibility of undetected duplicates. 
 
Whilst we compared SRA-DM against the typical default EndNote™ deduplication 
setting, we recognise that some information specialists adopt additional steps whilst 
performing deduplication in EndNote™. For example, they may employ multi-stage 
screening or attempt to replace incomplete citations by updating citation fields with 
the ‘Find References Update’ feature in EndNote™. However, many researchers 
and information specialists do not employ such techniques, and our aim was to 
address deduplication with an automated algorithm and compare it against the 
default deduplication process in EndNote™. Qi [18] recommended employing a two-
step strategy to address the problem of undetected duplicates by first performing 
auto-deduplication in EndNote™ followed by manual hand screening to identify 
remaining duplicates. This basic strategy is used by some information specialists 
and systematic reviewers but is inefficient due to the large proportion of unidentified 
duplicates. Other more complex multi-stage screening strategies have been 
suggested [25] but are EndNote-specific and not viable for other reference 
management software. 
 
Conclusions 
The deduplication algorithm has greater sensitivity and specificity than EndNote™. 
Reviewers and information specialists incorporating SRA-DM into their research 
procedures will save valuable time and reduce resource waste. The algorithm is 
open source [26] and the SRA-DM program is freely available to users online[27]. It 
allows similar file manipulation to EndNote™ and currently accepts XML, RIS and 
CSV file formats enabling citations to be exported directly to RevMan software. It 
has the option of automatic duplicate removal or manual pair-wise duplicate 
screening performed individually or with a co-reviewer. 
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Chapter 5 
Semi-automated citation screening 
 
 
 
Key steps for conducting a systematic review and where studies for this PhD are focussed 
  
Formulate a question
Check question is not already answered 
Compare biomedical databases (study 1)
Develop Protocol
Pre‐state method (inclusion criteria, search strategy, data extraction, 
outcomes, statistical analysis)
Search for studies 
Medline, EMBASE, Cochrane Central, grey literature,
contact authors/manufacturers

Remove duplicate citations  (study 2)
Screen citations for relevance 
Abstrackr machine learning evaluation (study 3)
PICo based title‐only screening (study 4)
Data extraction

Quality Assessment & Data Analysis
Write report
Interpret and communicate findings to stakeholders
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The previous chapter highlighted the problem of, and potential partial solution to, 
duplicate records retrieved from systematic searches of databases. The next stage 
of systematic reviewing, once the duplicate records are removed, requires screening 
the titles and abstracts of records to identify relevant studies for inclusion. Title and 
abstract screening is time-consuming for researchers and previous attempts at 
applying text mining to screening records have been inadequate because a 
threshold of 95% retrieval was used as an acceptable measure of success to 
identify relevant records. For systematic review purposes, this threshold is too low 
and would be unacceptable for commissioning bodies since 5% loss of data would 
potentially bias the findings.  More recently, semi-automated screening methods 
have been developed specifically for systematic reviews evaluated against higher 
thresholds of accuracy, but their suitability for systematic reviewing remained 
unclear due to limited research and lack of independent evaluation. 
 
In this chapter, the role of semi-automated screening is introduced and the current 
state of the technology. The limited evaluation surrounding text mining for 
systematic reviews and the absence of independent evaluation of existing text 
mining tools led to developing a research study evaluating the predictive screening 
software Abstrackr. The merits and demerits of text mining with Abstrackr are 
discussed and compared with the screening accuracy of manual screening and the 
diminishing returns of text mining with different systematic review topics. 
  
Summary 
The published study demonstrated that semi-automated screening with Abstrackr 
has the potential to reliably identify relevant citations through predictive screening 
and reduce workload from 9 to 80%. Nonetheless, in two datasets a small 
proportion of relevant abstracts were incorrectly predicted as irrelevant by Abstrackr 
and therefore caution is needed using Abstrackr as a stand-alone application. After 
the research was published in the journal, ‘Systematic Reviews’ the article received 
much interest from academic researchers and was listed as one of the most 
influential systematic review articles read in 201543.   
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5.1   Faster title and abstract screening? Evaluating Abstrackr, a 
semi-automated online screening program for systematic 
reviewers 
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Abstract 
Background 
Citation screening is time consuming and inefficient. We sought to evaluate the 
performance of Abstrackr, a semi-automated online tool for predictive title and 
abstract screening. 
 
Methods 
Four systematic reviews (aHUS, dietary fibre, ECHO, rituximab) were used to 
evaluate Abstrackr. Citations from electronic searches of biomedical databases 
were imported into Abstrackr, and titles and abstracts were screened and included 
or excluded according to the entry criteria. This process was continued until 
Abstrackr predicted and classified the remaining unscreened citations as relevant or 
irrelevant. These classification predictions were checked for accuracy against the 
original review decisions. Sensitivity analyses were performed to assess the effects 
of including case reports in the aHUS dataset whilst screening and the effects of 
using larger imbalanced datasets with the ECHO dataset. The performance of 
Abstrackr was calculated according to the number of relevant studies missed, the 
workload saving, the false negative rate, and the precision of the algorithm to 
correctly predict relevant studies for inclusion, i.e. further full text inspection. 
 
Results 
Of the unscreened citations, Abstrackr’s prediction algorithm correctly identified all 
relevant citations for the rituximab and dietary fibre reviews. However, one relevant 
citation in both the aHUS and ECHO reviews was incorrectly predicted as not 
relevant. The workload saving achieved with Abstrackr varied depending on the 
complexity and size of the reviews (9% rituximab, 40% dietary fibre, 67% aHUS, 
and 57% ECHO). The proportion of citations predicted as relevant, and therefore, 
warranting further full text inspection (i.e. the precision of the prediction) ranged 
from 16% (aHUS) to 45% (rituximab) and was affected by the complexity of the 
reviews. The false negative rate ranged from 2.4 to 21.7%. Sensitivity analysis 
performed on the aHUS dataset increased the precision from 16 to 25% and 
increased the workload saving by 10% but increased the number of relevant studies 
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missed. Sensitivity analysis performed with the larger ECHO dataset increased the 
workload saving (80%) but reduced the precision (6.8%) and increased the number 
of missed citations. 
 
Conclusions 
Semi-automated title and abstract screening with Abstrackr has the potential to save 
time and reduce research waste. 
 
Background 
Systematic reviews require a comprehensive search and appraisal of the literature 
to identify all relevant studies for inclusion. Typically, this involves a team of 
reviewers inspecting thousands of records that are produced from database 
searches. The large number of citations retrieved is partly due to the inadequate 
coding of studies indexed in biomedical databases such as MEDLINE and EMBASE. 
This produces imprecise search results; sometimes less than 1% of studies 
screened are included in a systematic review [1, 2]. Systematic reviews have also 
become more time consuming due to the growth in the volume and scatter of 
randomised trials [3], additional reporting steps [4, 5, 6], and the incorporation of 
more complex methodologies such as network meta-analysis and the acquisition of 
clinical study reports [7]. Consequently, many systematic reviews are out of date [8, 
9]. With all these challenges, there is a need to adopt techniques from computer 
science that can semi-automate screening in order to expedite the process of study 
selection. 
 
Text mining techniques are used to identify relevant information from text using 
statistical pattern learning that recognises patterns in data. Typically, such patterns 
are learnt from labelled training data that are then applied to datasets. A common 
application of such techniques is used to separate spam from real emails. Pattern 
recognition algorithms aim to provide the most likely matching of the inputs, taking 
into account their statistical variation. They have been applied in a variety of ways in 
evidence-based medicine to expedite tasks that would otherwise be omitted due to 
the time and cost involved if they were performed manually. For example, text 
mining has been used to assess the frequency of adverse effects of drugs by 
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analysing patient medical records [10] and to expedite scoping searches [11]. Text 
mining has the potential to reduce the workload of systematic reviewers by assisting 
with the identification of relevant trials during the title and abstract screening stage 
of a systematic review. 
 
Abstrackr [12] is a free, open-source [13], citation screening program, currently at 
beta testing stage that uses an algorithm within an active learning framework to 
predict the likelihood of citations being relevant. It uses text unigrams and bigrams 
within the annotated abstracts for the predictive modelling. Abstrackr biases the 
citations so that the most relevant are prioritised for screening first. Only limited 
research to date has been conducted into the strengths and limitations of semi-
automated citation screening [14, 15]. The aim of this study was to evaluate the 
performance of the Abstrackr algorithm. It was chosen for evaluation in preference 
to other text mining tools because existing literature indicates that the recall 
accuracy of Abstrackr is very high [14, 15, 16, 17], and therefore, a promising 
predictive text mining tool for systematic reviews, where the primary goal is to 
identify all relevant studies. 
 
Methods 
Four systematic review datasets derived from the literature searches of completed 
systematic reviews [1, 18, 19, 20] were used to evaluate Abstrackr. Three 
systematic reviews evaluated treatment effectiveness: dietary fibre interventions for 
colorectal cancer, rituximab and adjunctive chemotherapy interventions for non-
Hodgkin’s lymphoma, eculizumab for atypical hemolytic uremic syndrome (aHUS), 
and one diagnostic accuracy review of echocardiography (ECHO) was included. 
Each systematic review was chosen because of their different characteristics: for 
example, the aHUS review included all study designs except case reports; the 
interventions in the rituximab review included multiple chemotherapy interventions 
rather than a simple drug A versus drug B comparison; the dataset from the dietary 
fibre review was from a specialised register which provides a more homogeneous 
and smaller set of citations and therefore presents a challenge to supervised 
machine learning algorithms because they perform better on large datasets; and the 
ECHO was chosen because it is a diagnostic accuracy review*. 
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Citations were uploaded to Abstrackr, and titles and abstracts were screened for 
relevance by one author with relevant studies selected for inclusion and clearly 
irrelevant studies excluded. Screening continued until the algorithm’s stopping 
criterion indicated that predictions were available for viewing. This is based upon a 
simple heuristic requiring a set number of citations to be screened manually. The 
remaining unscreened citations were inspected according to the probability 
estimates and hard binary prediction made by the algorithm and cross-checked 
against the original review decisions. 
 
The performance of Abstrackr was assessed by calculating the precision, the false 
negative rate, the proportion missed, and the workload saving. The precision is the 
percentage of citations predicted relevant by Abstrackr that are subsequently 
deemed relevant by the reviewer for further full text inspection. The false negative 
rate is the percentage of citations that are relevant for further full text inspection but 
were predicted to be irrelevant by Abstrackr. The proportion missed is the number of 
studies missed by Abstrackr that were included in the published reviews, out of 
those studies predicted to be irrelevant. The workload saving is the proportion of 
citations predicted irrelevant out of the total number of citations. 
 
A post hoc sensitivity analysis was performed on the aHUS dataset because many 
of the included and excluded studies were methodologically similar, and therefore, 
excluding near matches might impede the learning algorithm. For example, case 
reports were originally excluded, but case series and RCTs were relevant and 
included. Therefore, by rescreening the aHUS dataset and also including case 
reports, we sought to determine if their inclusion would improve the machine 
learning precision by reducing superficially conflicting decisions. A post hoc 
sensitivity analysis was also performed on a substantially larger ECHO dataset to 
determine if this would affect the workload saving. 
____________________________________________________________ 
*For supplementary methodological details see appendix C 
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Results 
A total for four datasets from existing systematic reviews (aHUS n = 1415), (dietary 
fibre n = 517), (ECHO n = 1735) and (Rituximab n = 1042) were uploaded to 
Abstrackr and screened for relevance until the classification algorithm made 
predictions. 
 
Atypical haemolytic uremic syndrome dataset (excluding case reports) 
Of 1415 citations, 251 citations were screened (18%) before Abstrackr made the 
predictions, leaving 1164 (82%) citations unscreened. Of these, Abstrackr predicted 
that 374 citations were potentially relevant, and 63 were found to be relevant, giving 
a precision of 16.8% (Fig. 1). The false negative rate was 10% (Fig. 2). Of the 790 
citations predicted not relevant, one citation was included in the review, giving a 
percentage missed of 0.13% (Fig. 3). As 44% of citations required screening and 
checking for relevance, a workload saving of 56% was achieved (Fig. 4). 
 
 
 
Figure 1. Percentage of citations predicted by Abstrackr that were relevant for 
further full text inspection. *Raw numbers of the proportion of citations selected for 
inspection 
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Figure 2. False negative rate. *Raw numbers of the proportion of citations incorrectly 
predicted by Abstrackr to be irrelevant for further inspection 
 
 
 
 
 
 
 
Figure 3. Percentage of studies missed by Abstrackr—but were included in the 
reviews. *Raw numbers of the proportion of citations missed (predicted not relevant) 
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Figure 4. Workload saving (%) when using Abstrackr in each of the four datasets. 
*Raw numbers of the proportion of citations predicted not relevant from the total 
 
Sensitivity analysis of atypical haemolytic uremic syndrome dataset 
(including case reports) 
The citations were re-screened using the same decisions to include or exclude 
citations—with the exception that case reports were included (even though 
irrelevant). This ‘homogeneous’ screening method increased the precision from 16.8 
to 25.4% (Fig. 1) and the false negative rate was 14.3% (Fig. 2). The number of 
relevant citations missed, however, increased to two citations (0.21%) (Fig. 3). The 
workload saving increased from 56 to 67% (Fig. 3). 
 
Dietary fibre for colorectal cancer dataset 
Of 517 citations, 120 citations (23%) were screened before Abstrackr made 
predictions. Abstrackr predicted a further 190 were potentially relevant, and 47 were 
found to be relevant, giving a precision of 24.7% (Fig. 1). The false negative rate 
was 14.5% (Fig. 2). Of the remaining 207 citations predicted as not relevant by 
Abstrackr, none were included in the review—giving a 0% missed (Fig. 3). Sixty 
percent of citations required screening and checking for relevance, providing a 
workload saving of 40% (Fig. 4). 
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Echocardiography for stroke dataset 
Of 1735 citations, 122 (7%) were screened before Abstrackr made predictions. 
Abstrackr predicted that a further 619 were potentially relevant, and 181 were found 
to be relevant giving a precision of 29.2% (Fig. 1). The false negative rate was 4.7% 
(Fig. 2). Of the remaining 994 citations predicted as not relevant by Abstrackr, 993 
were correctly excluded; however, one citation that was included in the review was 
missed, giving a percentage missed of 0.10% (Fig. 3). Forty-three percent of 
citations required screening and checking for relevance, providing a workload 
saving of 57% (Fig. 4). 
 
Sensitivity analysis of echocardiography for stroke (large dataset) 
The citations were re-screened using a larger dataset of 15,920 citations to 
determine if precision and workload saving were affected. Abstrackr made 
predictions after 495 citations were screened and predicted that 2648 citations were 
potentially relevant. Of these, 181 were found to be relevant for full text inspection, 
giving a precision of 6.8%. The false negative rate was 21.7% (Fig. 2). Of the 
remaining 12,777 predicted as not relevant by Abstrackr, 12,775 were correctly 
predicted as not relevant. However, two citations that were included in the published 
review were missed, giving a percentage missed of 0.02%. Twenty percent of 
citations required screening, providing a workload saving of 80% (Fig. 4). 
 
 
Rituximab for Non-Hodgkins lymphoma 
Of 1042 citations, 130 citations (12%) were screened before Abstrackr made 
predictions. Abstrackr predicted 817 citations were potentially relevant, and 372 
were found to be relevant giving a precision of 45.5% (Fig. 1). The false negative 
rate was 2.4% (Fig. 2). Of the remaining 95 citations predicted as not relevant by 
Abstrackr, none were included in the review, giving a percentage missed of 0 
(Fig. 3). As 91% of citations required screening and checking for relevance, there 
was only a 9% workload saving (Fig. 4). 
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Discussion 
This study found that Abstrackr has the potential to reliably identify relevant citations 
and reduce workload from 9 to 80%. In two datasets, all relevant citations were 
identified, and in the other two datasets, only one citation was missed. The false 
negative rate ranged from 2 to 21%. Overall, precision was good although affected 
by the complexity of the review. 
 
In the aHUS dataset, precision was only 16.8%. This was due to the complexities of 
the study inclusion criteria which included case series as well as other higher quality 
study designs but not case reports that were excluded during screening. Because of 
the lexical similarity between case reports and case series, excluding case reports 
introduced greater variance into the machine learning algorithm with apparent 
conflicting decisions and consequently reduced precision. The sensitivity analysis 
demonstrated that by reducing ‘noise’, the precision could be increased. This 
problem of ‘noise’ with machine learning is common [21], and one strategy to 
increase precision during the data-training phase is to include close matching 
records [2], to ensure the active learning algorithm is not adversely affected, 
although this requires a degree of expertise to make decisions contrary to the 
PICOS (Participants, Interventions, Comparators, Outcomes and Study design) 
inclusion criteria. The ECHO sensitivity analysis had the worst precision (6.8%) 
because of the 15,920 citations wherein there was only about 0.9% that was 
relevant. Such imbalanced datasets are problematic for supervised machine 
learning models like Abstrackr, because the predictions are biased towards the 
majority non-relevant class at the expense of the minority-relevant class [22] and 
therefore produce many falsely weighted predictions, i.e. irrelevant citations. 
Nevertheless, this was off-set by the considerable workload saving. 
 
The false negative rates ranged from 2 to 21.7% and represent the percentage of 
citations that were relevant for further full text inspection but were predicted to be 
irrelevant by Abstrackr and were therefore ‘missed’. However, the actual percentage 
missed were in the range of 0 to 0.21% and represent the true final proportion of 
citation missed by Abstrackr that were included in the review. Therefore, the 
classification model was almost completely reliable. The citation missed from the 
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aHUS and ECHO datasets did not contain an abstract, only a title and therefore the 
probability of being predicted relevant was reduced. The aHUS sensitivity analysis 
missed two citations, and both contained no abstract. The ECHO sensitivity analysis 
missed two citations, one without an abstract, whilst the other did contain an 
abstract and it is unclear why this citation was not detected as relevant. However, 
these problems could be minimised by retaining citations without an abstract for 
manual inspection. 
 
The complexity of the review PICOS criteria also affected the workload saving. The 
workload saving in the rituximab dataset was low (9%) due to the rituximab 
intervention having multiple adjunctive chemotherapy treatments which overlapped 
with non-relevant studies. Therefore, the good precision and perfect recall accuracy 
with the rituximab data were off-set by the minimal workload savings suggesting that 
complex reviews may be less suited to semi-automated screening. Nevertheless, 
the average workload saving across the four datasets was 41% and is similar to the 
findings reported by the developers of Abstrackr who achieved a 40% saving in 
workload from two datasets[14]. 
 
Other data mining algorithms have achieved similar (40%) workload savings [16] but 
recall (identifying relevant records) was lower (90 to 95%), partly because testing 
was performed on datasets without a specifically associated research question. This 
makes comparisons with the results of this study difficult. Whilst another text mining 
algorithm [17] achieved workload savings ranging from 8.5 to 62% with 15 test 
datasets, which are similar to our findings with Abstrackr (9 to 80%), their results 
were based on a threshold of a minimum 95% recall of relevant studies, which is too 
low for systematic reviews. The developers of Abstrackr reported a recall accuracy 
of 100% for relevant studies from three genetics-related datasets and 99% for a 
fourth dataset, whilst the average specificity across the four datasets was 87% [14]. 
Their results were based on training the algorithm with balanced datasets, which 
have a similar number of relevant and irrelevant trials from the original systematic 
review, and using this trained algorithm to automatically find studies for the updates 
of the genetics-based systematic reviews. This approach is noteworthy since 
systematic reviews often require update searches to be performed within 2 years of 
the first published version [23], therefore, implementing this strategy, by retaining 
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the original classification model, would expedite the process of updating systematic 
reviews. 
 
Strengths and weaknesses of the research 
Our findings may be limited by the four datasets used, and citations from other 
clinical specialities may yield different precision and workload saving and miss more 
relevant studies for inclusion, especially if the title and abstract descriptions are 
inadequate or the study designs are more complex. Our datasets were from recently 
published systematic reviews that included trials published mostly from 1995 
onwards, and therefore, may contain better descriptions than older trials that were 
published before the CONSORT [24] reporting guidelines were introduced in 1996. 
Nevertheless, our results for identifying relevant trials are similar to the high recall 
results of Wallace (2010 and 2012) and indicate that similar accuracy could be 
achieved when using other datasets of medical citations. Previous text mining 
studies have mainly evaluated performance in terms of recall and specificity; 
however, our results also analysed the precision of the predictive model since this 
measures how precisely the algorithm selects studies for further full text inspection 
and mirrors the working steps of a systematic reviewer. Precision, however, is 
subjective and influenced by the reviewer’s expertise which can affect their 
screening judgements. The ECHO sensitivity analysis demonstrated that workload 
saving with semi-automated screening is more pronounced with large datasets, and 
therefore, greater savings could have resulted had we screened larger reviews. 
Nonetheless, the results provide a reasonable estimate of the algorithm’s typical 
performance during semi-automated screening. 
 
This study and others that have evaluated semi-automated screening with support 
vector models [14, 15], semantic vector models [16], and complement naïve Bayes 
models [17] indicate that considerable workload savings can be achieved. The 
ability to identify all relevant citations with Abstrackr was very high but imperfect. 
Such accuracy, however, is acceptable as a stand-alone tool for scoping searches 
and non-systematic reviews where not every published study needs to be included. 
It is noteworthy, however, that human citation screening is imperfect with relevant 
studies wrongly excluded [25]. Given that Abstrackr’s inaccuracy is similar to a 
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human screener, it could be utilised as the second screener. Abstrackr’s 
classification prediction model uses a somewhat arbitrary cut-off point at which the 
proportion of citations screened triggers the algorithm prediction. However, this 
suggests that an adjustable stopping heuristic could be used, so accuracy could be 
further improved albeit with the trade-off that more citations are screened during the 
training phase. 
 
Future developments with semi-automated screening would benefit from retaining 
the original classification model developed during the original review, so future 
systematic review updates may be screened automatically without the re-input of a 
reviewer. Abstrackr is not currently a consumer level product, and only the 
unscreened citations (the predictions) are exportable with only the title bibliographic 
details made available, and further developments are needed to create a fully 
integrated application that systematic reviewers and information specialists can use. 
 
Text mining algorithms have been proposed [26] to improve automated screening by 
including keywords to bias the predictive classification model so that citations 
containing such keywords are more likely to be identified.  This approach could be 
further aided by citation enrichment. For example, keywords of high relevance such 
as the PICOS details should improve the recall accuracy of semi-automated 
screening algorithms (and trial searching). Enriching citations is already being used 
for the EMBASE project [27] by coding citations with the type of study design 
through crowd sourcing. Further research and innovations in this underexplored 
area is needed to advance current methods, and eventually enable semi-automated 
screening to fully replace manual screening. Current text mining research [28] is 
focused on advancing screening retroactively and is restrained by the limitations of 
the data available. A more successful approach may require collaboration with 
biomedical database providers to ensure that citations are adequately labelled 
prospectively and retrospectively using strategies such as record linkage techniques, 
crowd sourcing, or access to a central repository, whereby PICOS details can be 
inputted and linked to all bibliographic databases. 
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Conclusions 
Semi-automated screening with Abstrackr can potentially expedite the title and 
abstract screening phase of a systematic review. Although the accuracy is very high, 
relying solely on its predictions when used as a stand-alone tool is not yet possible. 
Nevertheless, efficiencies could still be attained by using Abstrackr as the second 
reviewer thereby saving time and resources. 
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Chapter 6 
Screening citations using PICo based title-only screening 
 
 
 
Key steps for conducting a systematic review and where studies for this PhD are focussed 
  
Formulate a question
Check question is not already answered 
Compare biomedical databases (study 1)
Develop Protocol
Pre‐state method (inclusion criteria, search strategy,
data extraction, outcomes, statistical analysis)
Search for studies 
Medline, EMBASE, Cochrane Central, grey literature,
contact authors/manufacturers

Remove duplicate citations  (study 2)
Data extraction

Quality Assessment & Data Analysis
Write report
Interpret and communicate findings to stakeholders
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In Chapter 5, it was demonstrated that text mining technology via machine learning 
is becoming increasingly feasible for systematic reviews. Chapter 6 describes a new 
method of screening citations automatically by utilising Boolean operator title field 
search methods. The methods and results are discussed along with its application 
within the systematic review research community. 
 
Summary 
The following paper is complete in its original aims. Post hoc tests are currently 
being performed to test the application of PICo based title-only screening with a 
machine learning algorithm to determine whether the machine learning phase can 
be fully automated.   
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6.1    Expediting citation screening using PICo based title-
only screening for identifying studies in scoping searches 
and rapid reviews 
 
John Rathbone, Loai Albarqouni, Mina Bakhit, Elaine Beller, Oyungerel Byambasuren, 
Tammy Hoffmann, Anna Mae Scott, Paul Glasziou 
 
Abstract 
Background  
Citation screening for scoping searches and rapid review is time-consuming and 
inefficient, often requiring days or sometimes months to complete. We examined the 
reliability of PICo based title-only screening using keyword searches based on the 
PICO elements - Participants, Interventions, and Comparators, but not the 
Outcomes.  
 
Methods  
A convenience sample of 10 datasets, derived from the literature searches of 
completed systematic reviews, was used to test PICo based title-only screening. 
Search terms for screening were generated from the inclusion criteria of each 
review, specifically the PICo elements - Participants, Interventions and Comparators. 
Synonyms for the PICo terms were sought, including alternatives for clinical 
conditions, trade names of generic drugs and abbreviations for clinical conditions, 
interventions and comparators. The MeSH database, Wikipedia, Google searches 
and online thesauri were used to assist generating terms. Title-only searches were 
performed in Endnote X7 reference management software using OR Boolean 
operator. Outcome measures were recall of included studies and the reduction in 
screening effort. Recall is the proportion of included studies retrieved using PICo 
title-only screening out of the total number of included studies in the original reviews. 
The percentage reduction in screening effort is the proportion of records that do not 
need to be screened.  
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Results  
Across the 10 reviews the reduction is screening effort ranged from 11% to 78% 
with a median reduction of 53%. In 9 systematic reviews, the recall of included 
studies was 100%. In one review (oxygen therapy), 4 of 5 reviewers missed the 
same included study (median recall: 67%). A post-hoc analysis was performed on 
the dataset with the lowest reduction in screening effort (11%), and was rescreened 
using only the intervention and comparator 2 keywords, and omitting keywords for 
participants. The reduction in screening effort increased to 57% and the recall of 
included studies was maintained (100%).  
 
Conclusions  
PICo based title-only screening can expedite citation screening for scoping 
searches and rapid reviews by reducing the number of citations needed to screen, 
but requires a thorough workup of the potential synonyms and alternative terms. 
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Introduction 
There is no universal definition of what constitutes a scoping search although 
various criteria have been proposed [1],[2],[3]. In general, scoping searches are 
useful to attain a preliminary assessment of the size and scope of research literature, 
and to help assess the feasibility of conducting research, including determining 
whether clinical questions have previously been evaluated, or are up to date, and for 
estimating time-frames and budgetary considerations. Similarly, rapid reviews have 
no universally agreed upon definition but typically are a form of knowledge synthesis 
where some components of the systematic review process are simplified or omitted 
to produce information in a timely manner[4]. 
 
Scoping searches and rapid reviews both seek knowledge using a less formalised 
and rigorous methodology compared with systematic reviews. Rapid reviews 
attempt to expedite work by modifying tasks that traditional systematic reviews 
eschew due to the concerns over data loss[5]. Some tasks that are modified include 
literature searching, which may be expedited by restricting the number of databases 
searched[4], restricting by date range, language types[5], or omitting grey literature 
searches. Other strategies include restricting the number of personnel who screen 
studies, abstract data and assess risk of bias[4]. 
 
Citation screening of title and abstract is time-consuming because of the large 
number of citations typically retrieved (the average retrieval from a PubMed search 
produces 17,284 citations[6]) and is imprecise with often over 98% of citations from 
systematic searches excluded after title/abstract and full text 
screening([7],[8],[9],[10],[11],[12],[13],[14],[15],[16]). Titles of published studies 
typically incorporate the main components of a study design which can be 
categorised into the PICo components (Participants, Intervention, and 
Comparator, but not the Outcome). Therefore, screening restricted to the title field 
using the PICo components and the associated synonyms should identify the 
corpus of relevant studies whilst also being more precise, due to the constrained 
screening method. The aim of this study was to investigate the feasibility of 
conducting PICo based title-only screening primarily for scoping searches and rapid 
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reviews. 
 
Methods 
A convenience sample of 10 datasets derived from the literature searches of 
completed systematic reviews was used to test the PICo based title-only screening. 
Seven datasets[7],[9],[10],[11],[12],[14],[16] available to the authors were used, and 
an additional 3 datasets[8],[13],[15] were created by replicating the search strategy 
from the published reviews. These three reviews were selected prima facie based 
on being intervention studies that contained adequately reported search strategies 
and study inclusion details. We used a convenience sample of 5 reviewers, (3 
clinicians, and 2 non-clinicians) based at the Centre for Research in Evidence-
Based Practice, Bond University to assess the reliability and reproducibility of PICo 
based title-only screening. Each reviewer screened all 10 systematic reviews, and 
had prior knowledge of evidence-based practice and systematic review 
methodology. 
 
Each reviewer independently compiled a list of search terms derived from the 
inclusion criteria of the reviews, specifically, the (P) Participants, (I) Interventions 
and (C) Comparators, but not the Outcomes. PICo synonyms including drug trade 
names and alternate names for clinical conditions were sought in MeSH database, 
Wikipedia, online thesauri and Google searches. Typically, 3-4 synonyms were 
generated for each term, but there was no restriction on the number of terms (see 
appendix 1). Keywords with both British and American spellings were used, and 
keywords with different suffixes were truncated using an asterisk. PICo based title-
only searches were performed in Endnote X7 reference management software 
using ‘OR’ Boolean operator (see appendix 2). 
 
Outcome measures (Box 1) were the recall of included studies and the reduction in 
screening effort (RSE). Recall is the proportion of included studies retrieved using 
PICo title-only screening out of the total number of included studies in the original 
reviews. The percentage reduction in screening effort is the proportion of records 
that do not need to be screened. This was reported individually for each reviewer, 
and as the median value across the 5 scores. A post-hoc analysis was performed 
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with one of the datasets (Parkinson’s) to examine the impact of screening using only 
keywords for the (I) intervention and (C) comparator and omitting keywords for (P) 
participants. 
  
ݎ݈݈݁ܿܽ	ሺ%ሻ ൌ ݊ݑܾ݉݁ݎ	݋݂	݈݅݊ܿݑ݀݁݀	ݏݐݑ݀݅݁ݏ	ݎ݁ݐݎ݅݁ݒ݁݀ݐ݋ݐ݈ܽ	݊ݑܾ݉݁ݎ	݋݂	݈݅݊ܿݑ݀݁݀	ݏݐݑ݀݅݁ݏ ൈ 100 
ܲݎ݁ܿ݅ݏ݅݋݊ ൌ ܰݑܾ݉݁ݎ	݋݂	݈݅݊ܿݑ݀݁݀	ݏݐݑ݀݅݁ݏ	ݎ݁ݐݎ݅݁ݒ݁݀ܶ݋ݐ݈ܽ	݊ݑܾ݉݁ݎ	݋݂	ݎ݁ܿ݋ݎ݀ݏ	ݎ݁ݐݎ݅݁ݒ݁݀  
ܵܿݎ݁݁݊݅݊݃	݂݂݁݋ݎݐ	ሺܵܧሻ ൌ 1ܲݎ݁ܿ݅ݏ݅݋݊ 
ܴ݁݀ݑܿݐ݅݋݊	݅݊	ݏܿݎ݁݁݊݅݊݃	݂݂݁݋ݎݐ	ܴܵܧ	ሺ%ሻ ൌ ܵܧ௠௘௧௛௢ௗଵ಩ െ ܵܧ௠௘௧௛௢ௗଶ‡ܵܧ௠௘௧௛௢ௗଵ಩ ൈ 100 
Box 1.  
Recall of included studies 
Reduction in Screening Effort (RSE) 
†method1 is current pracƟce (screening all records). 
‡method2 is PICo based title‐only screening. 
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Results 
Ten systematic reviews were evaluated with a total of 31,359 records. Reduction in 
screening effort across the reviews (Figure 1) ranged from 11% (Parkinson’s review) 
to 78% (Phenytoin review) with a median reduction in screening effort of 53%.  The 
recall of includable studies was 100% in 9 of the 10 reviews. In the oxygen therapy 
review, 4 of 5 reviewers missed the same included study (median recall: 67%). 
 
 
 
Figure 1  
Summary of the median reduction (|) in screening effort, the individual reviewer reduction in 
screening effort (coloured dots), and the percentage of citations remaining that are needed to 
screen across 10 systematic reviews using PICo based title-only screening. 
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Post-hoc analysis 
The minimal reduction in screening effort in the Parkinson’s dataset was principally 
due to the keyword ‘Parkinson’ retrieving 80% of all records. A post-hoc analysis 
was performed to determine if complete recall could be maintained and reduction in 
screening effort improved when relying only on keywords for the intervention(s) and 
comparator(s), but not the participants.  Screening without type of participants 
improved the median reduction in screening effort from 11% to 57%, and the recall 
of included studies was 100% (Figure 2). 
 
 
 
Figure 2.  
Summary of the individual reviewer reduction in screening effort using PICo based title-only 
screening (◼) and Intervention and Comparator based title-only screening (◼), and the 
percentage of citations remaining that are needed to screen for the Parkinson’s dataset. 
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Discussion 
Our results indicate that PICo based title-only screening considerably reduces the 
workload of citation screening, maintains high recall of relevant studies, and can be 
used to expedite scoping searches and rapid reviews.  
 
Reduction in screening effort 
The reduction in screening effort ranged from 11 to 78% with 7 of the datasets 
having a reduction in screening effort above 50%. The two prognostic review 
datasets (Prostate and Thyroid cancer) had a median reduction in screening effort 
of 12% and 19%, however, these reviews used a more focused search and are 
atypical of most search strategies.  The post-hoc analysis was undertaken because 
the reduction in screening effort was minimal in the Parkinson’s dataset due to 80% 
of the citations containing the keyword ‘parkinson’ or variations e.g. ‘parkinsonian’ in 
the title field, and therefore the median reduction in screening was only 11%; the 
post-hoc analysis found that restricting the PICo search terms to only the 
intervention and comparator maintained 100% recall and improved the reduction in 
screening effort to 57%.  This could be a useful strategy to maintain precision where 
a particular PICo term is overrepresented within a dataset and minimal reduction in 
screening effort is achievable when initially screening using all 3 PICo search terms. 
 
The median reduction in screening effort was 53% but varied considerably from 11% 
to 78%. PICo based title-only screening would be of limited benefit to expedite tasks 
when the reduction in screening is only 10-20%, unless datasets were large (unlike 
the prostate and thyroid cancer datasets), but for searches that are not highly 
focused considerable saving can be achieved. In addition, general searches 
conducted in MEDLINE typically produce over 17,000 citations44, suggesting that 
most searches are not highly focused and these would also benefit by applying 
PICo based title-only searching. Care must be taken to ensure British and American 
spellings and suffix variations are incorporated into the keywords screening, and 
that compound terms e.g. ‘transoesophageal echocardiography’ are entered as 
separate search terms to allow for variations in word order, otherwise relevant 
citations could potentially be missed when using PICo based title-only screening.  
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Recall 
The recall was 100% in 9 of 10 systematic reviews. One reviewer, a clinician, 
identified all included studies across the 10 reviews including the oxygen therapy 
review; however, 4 reviewers missed the same included study in the oxygen therapy 
review. ‘Ventilation’ was used in the title as an alternative term for oxygen therapy, 
and this was not listed in the MeSH database, nor found whilst searching other 
resources, and therefore subject knowledge was needed to identify the study.  
Nonetheless, for other datasets PICo based title-only screening was reliable.  
 
Strengths and limitation of the research 
The strengths in this study were that 10 datasets were used to test the hypothesis 
that using PICo based title-only screening could retrieve all studies that should have 
been found and reduce the number of citations to screen. Also, the results were 
reproducible for recall in 9 of 10 datasets, and the methodology is simple and easily 
implemented by reviewers or information specialists with knowledge of screening 
and Endnote software. The datasets used were a convenience sample and 
reduction in screening effort may differ with different clinical specialities and study 
designs. Nonetheless, in this study, the sample of reviews tested included a variety 
of clinical specialties, different types of interventions and different study designs, 
such as diagnostic accuracy, prognostic, and intervention studies.  
 
Applicability  
The limiting factor for the applicability for screening is the presence or absence of 
either controlled or consistent vocabulary. The high recall and improvement in the 
reduction in screening effort was due to the sample datasets using clearly defined 
terms for (P) clinical conditions, (I) interventions and (C) comparators, but using 
PICo based title-only screening where the ontology is less clearly defined (e.g. 
where there are no MeSH terms indexed) could potentially affect recall; in such 
scenarios PICo based title-only screening may be unsuited for rapid review but 
would remain useful for scoping searches since identifying all studies is not the 
objective. This potential for error, however, could be allayed by including topic 
experts to help compile search terms. However, it has been shown that the retrieval 
of relevant studies for inclusion can be impaired in rapid reviews when the number 
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of databases searched, or the number of screeners is restricted[17]. Similarly, 
traditional title and abstract screening for systematic review can be imperfect with 
relevant studies wrongly excluded[18]. This screening methodology could also be 
applied to systematic review screening where one reviewer examines all records 
whilst a second reviewer screens the sub-set identified from PICo based-title 
screening.  
 
This study has examined expediting screening on the assumption that titles of 
articles will include at least one of the PICo components to enable a focused title-
based search to identify all relevant studies and minimise the number of citations to 
screen. Other methods have been developed to expedite screening using semi-
automated predictive algorithms that ‘learn’ to distinguish relevant and irrelevant 
citations[19]. The recall and reduction in screening effort from PICo based title-only 
screening are similar to those achieved with semi-automated predictive 
algorithms[19],[20],[21]. However, semi-automated screening algorithms require an 
initial training-set (typically ~25% of the total citations) to be manually screened in 
order to train the algorithm. This step could be expedited by incorporating PICo 
based title-only screening to generate a sub-set of citations to train the algorithm 
and dispense with manual training. Further work is needed to explore how PICo 
screening can be incorporated into machine learning technologies to further 
accelerate the training of datasets.  
 
Conclusion  
PICo based title-only screening can expedite citation screening for scoping 
searches and rapid reviews by reducing the number of citations to screen, but 
requires a thorough workup of the potential synonyms and alternative terms.  
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Abbreviations: 
 
MEDLINE: Medical Literature Analysis and Retrieval System Online 
MeSH: Medical Subject Headings  
PICo: Participant, Interventions, Comparators, outcomes 
RSE: Reduction in Screening Effort 
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Appendix 1. Example of PICo based search terms used for screening  
Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-
Analysis  
 
Inclusion criteria: 
 
Participants - People with stroke or transient ischaemic attack 
Intervention - Clopidogrel and aspirin 
Comparator - Aspirin 
 
PICo  Alternate name Alternate name Alternate name
Stroke Intracranial Embolism 
and Thrombosis  
Intracranial 
Arteriosclerosis 
 
Transient ischaemic 
attack 
TIA Brain Stem Ischemia Transient Cerebral 
Ischemia 
Clopidogrel plavix iscover  
Aspirin Acetylsalicylic acid 
 
ASA 2-(Acetyloxy)benzoic Acid 
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Appendix 2.  
Example of PICo based title-only screening using OR Boolean operator in 
Endnote reference management software (Oxygen therapy)  
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Discussion 
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7.1   Summary 
This chapter briefly contextualises the development of systematic reviews and the 
current impasse which has provoked the need for automation technologies. It 
discusses the four individual studies and how they have contributed to the field of 
automation, summarises the thesis findings including the strengths and limitations of 
current automation technologies, the barriers and facilitators to the development and 
implementation of automation technologies, suggestions to assist with the 
actualization of automation technologies, and concluding remarks.   
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7.2 Overview of research problem 
Systematic reviews developed from the need identified in the 1970s to establish a 
corpus of evidence by medical specialty to inform clinicians of best practice using 
unbiased, reliable and reproducible methods. By the 1990s this approach had 
begun to replace opinion-based medicine with Evidence-Based Medicine (which 
includes but is not limited to systematic reviews); however, the proponents of EBM 
did not foresee the growth in research and the consequent increased costs and 
unsustainability of research synthesis. Consequently, organisations such as the 
Cochrane Collaboration struggled to ensure reviews remained up to date as new 
trial data were published and ultimately were forced to down-grade their idealistic 
goals, as envisioned by Archie Cochrane.  The focus, understandably for such 
organisations, has been to improve the quality of systematic reviews. This has led to 
the introduction of incremental improvements, e.g. risk of bias assessment, 
summary of findings tables, PRISMA flow charts and checklist. However, the validity 
of each review is undermined when the latest trial data are not incorporated in a 
timely manner, and undermines the raison d'etre of the Cochrane Collaboration - to 
produce the best available evidence. 
 
7.3 Development of an international collaboration 
More recently, there has been wider recognition of the unsustainability of research 
synthesis and consequently an initiative was taken in 2015 that led to the formation 
of the International Collaboration for the Automation of Systematic Reviews 
(ICASR)45 by groups of researchers who are interested in progressing the 
automation of systematic reviews. The purpose of the collaboration was to discuss 
the development of automation technologies, and to produce policy documents 
which set out their aims and objectives, and to delegate tasks to groups with the 
appropriate expertise. This is an important step in recognition of the potential of 
technology to assist with the problems facing systematic reviewers. It is also the 
beginning of an effort to coordinate strategies to overcome these problems, which 
has been largely absent from the policy documents of organisations responsible for 
the production of systematic reviews.  
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It was with a similar interest to those principles established by ICASR that this PhD 
developed, with many of the objectives of ICASR overlapping with this body or work. 
Additional interest arose from personally observing and experiencing the 
inefficiencies and lack of progress towards better working practices for secondary 
health research. The different tasks required of a systematic review pose different 
challenges with some of those tasks being more readily automatable than others, 
since current technology is unable to automate all the tasks. Different approaches 
have been pursued by automation teams with some endeavours being partially 
successful but with seemingly insurmountable barriers to further progress46, whilst 
others have proven to be fully automatable yet have remained as conceptual 
research requiring additional impetus to produce a consumer product47. The four 
projects undertaken in this PhD have contributed to our understanding of the 
strengths and limitations of semi-automation techniques. Furthermore, the projects 
have enhanced our understanding of how automation can be used for future 
adaptation and/or integration with other systems, or replaced with better systems as 
they are developed.  
 
7.4   Comparing bibliographic databases  
This study was devised to investigate the performance and reliability of biomedical 
databases as a resource for identifying systematic reviews. This research question 
and its findings were unique because no previous research had examined the 
performance of biomedical databases for identifying systematic reviews. The 
findings illustrated that EMBASE had the best sensitivity but with a trade-off with 
specificity and therefore greater numbers of records to screen. In contrast, the 
Cochrane library had a clear advantage with specificity, and therefore fewer records 
to screen. However, none of the databases identified all the systematic reviews and 
the use of search filters was a limitation affecting the sensitivity of biomedical 
databases.  
 
Since the paper was published, some of the smaller bibliographic databases have 
expanded their content substantially due to incorporating other database provider’s 
content e.g. PubMed records have been added to TRIP database and this may have 
improved the sensitivity of searches.  Biomedical databases such as PubMed are 
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also affected by the growth in research which is impacting on the ability of PubMed 
to continue coding citations with medical subject headings (MeSH) which are used 
to improve record retrieval by indexing articles in the database with a controlled 
vocabulary thesaurus that enables users to search at various levels of specificity. 
The increasing costs are not sustainable and in the future if PubMed abandons 
adding MeSH terms to citations researches will face additional challenges to identify 
trials. Text mining will become crucial to searching for studies if MeSH terms are 
discontinued and this may have the unexpected benefit of spurring on further 
research. 
 
7.5   Deduplication 
Record deduplication has previously been overlooked as a research priority for 
systematic reviews and researchers have been dependent upon existing software 
which has barely advanced since its inception. The deduplication algorithm 
developed in this research project is noteworthy, having progressed from pure 
academic enquiry into a fully operational open access application which is now used 
by researchers throughout Europe, Australasia and North America. Several 
organisations including the UK Cochrane Collaboration, and Covidence in 
Melbourne, Australia are investigating integrating the deduplication application into 
their software systems. The National Institute for Clinical Excellence, in the UK, is 
proposing to develop a similar fuzzy-logic deduplication program, and is using the 
datasets compiled during the PhD research for their own evaluation. The 
deduplication research project is an example of advancing existing processes, 
however, scope remains to improve duplicate detection using strategies previously 
outlined in chapter 4. How this will be pursued in the future is unclear because of the 
limited resources currently committed to this field of research.  
 
7.6 Title and abstract screening - Abstrackr 
The third study was devised to investigate the feasibility and reliability of semi-
automated screening. The current practice of reviewers manually screening 
thousands of citations can take weeks or months to complete and is one of the 
biggest time-consuming steps for reviewers, and therefore one of the more 
106 
 
important tasks to automate. The research demonstrated the potential benefits that 
semi-automated screening can provide with reducing screening effort by up to 80%.  
 
The paper was cited as one of the most influential papers published by BioMed 
Central43 in 2015. Since the publication, research interest in automation 
technologies has continued to grow with Howard (2016)48 developing a text mining 
algorithm to rank citations by relevance (similar to EPPI-Reviewer49 software). Text 
mining algorithms have also been developed with the aim of achieving high recall by 
incorporating ‘voting’ strategies50 that prioritise citations that receive at least one 
vote. Other techniques have been explored to expedite citation screening by utilising 
citation networks which assume that studies meeting the inclusion criteria of a 
systematic review will form a network of connectivity where studies are co-cited 
either directly or indirectly. Belter (2015)46 investigated this concept as an alternative 
literature search method for expediting the identification of studies and found that 
the screening effort was reduced by over 50%; however, recall was only 74%. One 
barrier encountered was that some studies included in the reviews (but not retrieved 
by citation searching) were not indexed in Web of Science. Recall could have 
potentially been improved by also including Scopus and Google Scholar to improve 
coverage; however, many of the studies were missed simply because the citation 
network was incomplete, and therefore citation network searching is unlikely ever to 
replace current information retrieval methods.  
 
Priority should be given to further developing automation tools into consumer level 
applications that have demonstrated good reliability, such as machine learning 
citation screening algorithms because they are not hindered by the same seemingly 
insurmountable barriers associated with for example, citation analysis which data 
mines citation relationships between articles. Such tools will probably achieve 
greater reliability compared with human operators. Tasks requiring subjective 
assessment or the synthesis of complex data, may be beyond the current 
capabilities of automation technologies and will continue to rely on human expertise. 
Semi-automation tools, however, could still provide a supportive role for the 
synthesis of complex data. For example, extracting numerical data from graphs has 
been made easier with WebPlotDigitizer51 which is a web based tool that helps 
convert data plots into number values.   
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Text mining tools are currently at an early stage of development and adoption of 
such technologies has been slow due to a combination of lack of awareness, 
reliability doubts, and compatibility issues. Many of the earlier algorithms were 
developed for applications where perfect recall was not the main priority52, and 
developers have questioned the feasibility of whether text mining tools can ever 
meet the expectation of perfect recall for a systematic review53. Such pessimism 
was understandable two decades ago, when text mining applied to systematic 
reviews was in its infancy. Text mining algorithms are feasible when applied to 
systematic reviews of randomised controlled trials of drug interventions, with results 
typically ranging from 99% to 100% for recall because the terminology is mostly 
standardised. However, applying text mining to reviews with less structured 
vocabulary, such as in the social sciences could be more challenging. Nevertheless, 
it is questionable if a small loss of data would be critical to the outcome of 
descriptive systematic reviews which use thematic analysis. Nonetheless, relatively 
little research has been conducted into text mining for systematic reviews and its 
potential strengths and limitations remain underexplored. 
 
7.7   PICo based title-only screening 
The fourth study investigated the potential strengths and limitations of screening 
citations using PICo based title-only screening as an alternative to manually 
screening citations for rapid reviews and scoping searches. The methodology is a 
unique approach to screening, relying on the premise that titles will include at least 
one of the three main PICo terms and therefore capture relevant records using a 
more focused searching method. The results validated that premise and 
demonstrated either very high or perfect recall accompanied by about 50% 
reduction in screening. The reduction in the screening effort and the high recall were 
similar to the findings in the Abstrackr publications and suggest that this 
methodology can be incorporated into machine learning algorithms to replace the 
‘learning’ phase with instantaneous ‘forced learning’ to train the algorithm. 
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7.8   Direction of future research 
There are many technical and collaborative challenges confronting automation 
technologies. These challenges need to be overcome or new technologies risk 
becoming mere academic curiosity, stuck at beta development stage without 
progressing to a consumer product. Technical problems that developers encounter 
include restricted access to online biomedical databases, journals, and trial 
registries due to commercial restrictions or paywalls54. Also, many database 
providers are unwilling to provide access to application programming interface (API) 
keys which allows unrelated software programs to communicate with one another.  
Objections to accessing API keys include citing copyright restriction (this was 
encountered during research in Chapter 3), even though the information is in the 
public domain, albeit in a format that prevents the automation of tasks that are 
currently performed manually such as citation analysis or citation enrichment. To 
overcome these barriers a protocol needs to be developed amongst the stake 
holders similar to those developed by DICOM (Digital Imaging and Communications 
in Medicine) which is a standard for distributing and viewing any type of medical 
image55,56.   
 
Unrestricted full text access could facilitate, for example, the use of screen scraping 
tools to replace manual data entry of citation details. Other issues include lack of 
agreement on technical standards preventing integration of different programming 
platforms which need to be overcome with an agreed standard to allow ‘plug and 
play’ systems. There are different strategies to automate systematic reviews and 
some will be more challenging because of technical barriers e.g. fully automating 
data extraction due to the multitude of different ways numerical results can be 
reported (in tables, graphs, as proportions, dichotomised data as improved/not 
improved). Also studies often classify patients differently when describing severity of 
illness, or provide insufficient information and would therefore thwart automation. As 
processes become increasingly automated fewer gains will be achieved with 
diminishing returns for the investment in development time. Collaborative barriers 
will prevent automation due to organisations wishing to either dominate a service or 
maintain current market position due to commercial interests. Some automation 
processes will save time and also improve accuracy such as automated results 
109 
 
writing tools which have the potential to reduce human error but more importantly 
provide an idealised text that is more meaningful and comprehensible to readers. 
Other automation tasks will transform current practice and substantially save time 
such as automated screening tools which can reduce the screening content by as 
much as 80% and save weeks of work. Some of the tasks that are either in current 
development or would benefit from automation include:  
 
1. Replace tasks that are currently manually performed such as citation screening 
and data abstraction with machine learning algorithms.   
 
2. Improve existing but imperfect semi-automation methods, e.g. duplicate detection 
in reference management software packages such as EndNote™ with more 
accurate systems such as SRA-deduplication tool, and strive for fully automated 
duplicate detection. 
 
3. Continually improve existing screening applications such as Covidence, Rayyan 
and DistillerSR so that new applications can be easily incorporated once they 
become available, enabling apps to be downloaded and installed. This would 
overcome some current limitations that require data to be exported and reformatted 
from one program to another.  
 
4.  Expedite and improve the accuracy of the reporting of systematic reviews, e.g. 
improving the protocol, background, methods, results and discussion sections by 
pre-populating with a selection of structured sentences to improve comprehension. 
Automate writing of results using the pre-populated structured data within statistical 
programs to generate text describing the direction and size of treatment effects.  
 
5. Prioritise the automation of tasks that are time-intensive e.g. citation screening, 
data abstraction. Prioritise automation tools that have demonstrated proof of 
concept but have not been further developed into a consumer level product. 
 
Many of these research priorities are at different stages of development. Some have 
been investigated and have shown initial promise, such as predictive screening 
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tools like Abstrackr47, or visual text mining techniques57 but have not progressed to 
consumer level applications, whilst other applications are in the early stage of 
development such as RevMan Replicant which will eventually populate the results 
section of a systematic review with a first draft describing the size, direction, and 
significance level of the treatment effect.  Another example, is a machine learning 
program called RobotReviewer35 that has recently been developed to expedite the 
assessment of risk of bias in Cochrane and non-Cochrane systematic reviews.  The 
accuracy is slightly lower (~<10%) compared with human screening decisions; 
however, because the algorithm highlights relevant text it can assist reviewers to 
find information when used as a companion tool, or as an algorithmic second 
reviewer. 
 
Research priorities will vary according to organisational needs and other automation 
tasks may take precedence. Future decisions on how best to prioritise research 
need to consider the current and future state of technology which may either restrict 
or enable automation. For example, future developments such as record linkage 
across biomedical databases could foreseeably enable citation enrichment and 
therefore supersede the need for additional research into duplicate detection. Also, 
workflows may change as automation processes develop. For example, PICo based 
title-only screening could be used to conduct an initial search across biomedical 
databases, followed by a machine learning algorithm that incorporates this data to 
complete the fully automated search, including citation analysis and future periodic 
update searches. As machine learning improves, the excluded studies in published 
systematic reviews could also be used to provide a feedback loop to enhance 
machine learning algorithms. 
 
Commercial and non-commercial groups are independently developing software 
applications to facilitate automation. Most products available as consumer level 
products have been developed to assist with the screening, organisation and 
cataloguing of records within systematic reviews. For example, screening tools have 
improved the visual experience of selecting studies and assist with the tracking of 
conflicting screener decisions.  The main benefits of these tools are primarily to 
improve the organisation of data, reduce human error, and improve the user 
experience above expediting tasks, although inevitably these improvements can 
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save time.  The Cochrane group’s own software, RevMan, automatically calculates 
summary statistics from structured data, generates forest plots and calculates 
statistical bias. Most of these developments have occurred independently and 
integrating automation tools into different software has been challenging because of 
different programming languages. Greater co-operation is needed to have a set of 
agreed standards to facilitate automation research including open source code and 
a mechanism for different software to communicate with one another by way of a 
standard application programming interface key, or a platform enabled to integrate 
different applications with ‘plug and play’ standardisation.   
 
The limited replication of validating automation technologies, e.g. predictive citation 
screening makes it difficult to assess its applicability in other healthcare specialties 
where the ontology is less clearly defined.  Independent evaluation of automation 
technologies is needed to validate initial findings and to test how well technologies 
perform when applied in different contexts with different datasets. By necessity, 
most technologies are tested on small datasets due to limited resources because 
validation is often the biggest development cost for automation technologies. 
Attempts to overcome some of these problems have been proposed by ICASR45. 
The working group developed a set of core principles (The Vienna Principles – see 
Box 1) which includes encouraging collaboration between automation research 
groups. Each automation group has different types of expertise and by collaborating 
and sharing ideas barriers to progress can be more readily overcome.  
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Box 1. The Vienna Principles 
1. Systematic reviews involve multiple tasks, each with different issues, but all 
must be improved. 
2. Automation may assist with all tasks, from scoping reviews to identifying 
research gaps as well protocol development to writing and dissemination of the 
review. 
3. The processes for each task can and should be continuously improved, to be 
more efficient and more accurate. 
4. Automation can and should facilitate the production of systematic reviews that 
adhere to high standards for the reporting, conduct and updating of rigorous 
reviews. 
5. Developments should also provide for flexibility in combining and using, e.g. 
subdividing or merging steps and allow for different users to use different 
interfaces. 
6. Different groups with different expertise are working on different parts of the 
problem; to improve reviews as a whole will require collaboration between 
these groups. 
7. Every automation technique should be shared, preferably by making code, 
evaluation data and corpora available for free. 
8. All automation techniques and tools should be evaluated using a 
recommended and replicable method with results and data reported. 
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7.9   Barriers and facilitators to adopting automation technologies  
7.9.1 Barriers 
How quickly researchers and organisations adopt semi-automation technologies is 
speculative. Some of the barriers may be psychological, especially if organisations 
are averse to risk e.g. concerning data loss, or reluctant to incorporate new 
technology, especially larger organisations that may be less flexible.  For example, 
web-based screening tools are available that visually enhance screening and track 
and alert reviewers of conflicting decisions, but many organisations continue to use 
older working practices. Financial barriers may exist as some programs are fee 
based, but these costs would be off-set by greater efficiency and by eliminating 
mundane tasks. Free software that are at the beta-developmental stage will not 
have extensive technical support and users may not persist if technical problems 
are encountered.  
Systematic review automation is not restricted by government regulations, safety 
standard requirements, or large scale development costs such as occurs in the 
aviation industry58.  Rather, concerns over the accuracy and reliability will be the 
main barrier to accepting automation technologies even though existing processes 
are fallible due to human or technological errors.  Algorithms are more reliable when 
performing tasks such as citation screening and results writing because the 
information uses controlled vocabulary, but becomes less reliable when using data 
that is less well-structured, such as the assessment of risk of bias, or extracting 
outcome data.  However, this should not be a barrier to integrating these 
technologies because they could provide a complementary role, but would require 
co-validation of the machine learning decisions by reviewers.  
Often barriers to adopting more efficient working practices are less obvious when 
viewed externally. For example, within the Cochrane collaboration study-based 
registers were developed in the 1990s, but only implemented by 12 Cochrane 
groups by 200559 even though the long-term benefits outweighed the initial set-up 
time and costs. Study-based registers produce highly specific search results, free of 
duplicates, with secondary publications linked to primary studies. Financial 
constraints may have prevented some groups from establishing a study-based 
register; however, some groups may have been less inclined to adopt study-based 
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registers because the main beneficiaries were the academic researchers working 
voluntarily for the Cochrane groups who bore the burden of these inefficiencies.  In 
a report commissioned by the UK Department of Health25, on the future investment 
in UK Cochrane groups, it was noted that some groups had a number of resources, 
generated from National Institute for Health Research funding, including specialist 
registers and recommended that Cochrane investigate how these resources can be 
shared. 
 
7.9.2 Facilitators 
Facilitators to increase in the adoption of automation tools include rigorous 
evaluation and dissemination of the benefits of these technologies through journal 
publications, scientific conferences and social media. The integration of 
technologies by large organisations such as Clarivate Analytics, Mendeley, the 
Cochrane Collaboration, and the National Institute for Health and Care Excellence 
would greatly increase the awareness and adoption of automation technologies. 
Large organisations are also more readily able to offer technical support and provide 
resources for ongoing development and therefore users will be more confident to 
transition to new software and working practices.   
 
7.10 Systematic reviews as a marketing tool 
Systematic reviews have contributed to our understanding of the benefits and harms 
of treatment, and there have been many noteworthy reviews that have changed 
healthcare dramatically including identifying the harms of radiotherapy in early stage 
breast cancer11, identifying the benefits of corticosteroids to increase survival rates 
in preterm pregnancies60, and identifying the benefits of streptokinase to reduce 
death in acute myocardial infarction61. Preventative medicine has also benefited 
from systematic review methodology by identifying the increased risk of lung cancer 
from ‘second-hand’ cigarette smoke exposure62. However, systematic reviews are 
not without criticism from the advocates of evidence-based medicine.  
Some proponents of evidence-based medicine have argued that evidence-based 
medicine has become a marketing tool for the pharmaceutical industry63, and has 
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been hijacked so that clinical medicine has been transformed into finance-based 
medicine64. Is it possible that systematic reviews rather than being a stalwart for 
evidence-based medicine are providing a ‘rubber stamp’ of approval for the 
pharmaceutical industry? Such criticism is not without supporting evidence and 
there are many examples where research findings were found to be misleading. 
Studies have shown a correlation between financial interest and positive outcomes. 
For example, a comparison of 319 trials examining industry-sponsored and non-
industry sponsored trials found that industry sponsored trials tended to yield 
favourable results for the experimental treatment65. It is known that industry 
sponsored trials typically avoid comparing their own drugs against competitors’ 
products66, and industry-sponsored trials are more likely than other trials to conclude 
that a drug is safe67. Our understanding of the effectiveness of drugs can be 
overturned when new data from previously withheld trials emerge. An example is 
the antiviral drug Tamiflu, which was thought to reduce the risk of pneumonia and 
death in patients infected with the influenza virus when the evidence for its benefits 
were first published. However, not all the studies had been published and following 
a lengthy wrangle to acquire unpublished data the updated review found that 
Tamiflu had limited effect on the complications of influenza22,68. Similarly, the 
selective serotonin reuptake inhibitor class of antidepressants have been shown to 
increase the risk of suicide in children69. However, the original studies did not reveal 
this problem because either the trial data remained unpublished or patients 
attempting suicide were misleadingly categorised as ‘overdoses’.  
It is not clear if these are isolated problems or are emblematic of a wider problem in 
evidence-based medicine. Identifying these problems can be difficult due to the 
hidden nature of missing data. Contacting regulatory agencies to acquire clinical 
study reports is a lengthy procedure, which sometimes can only be obtained through 
persistence and use of the Freedom of Information Act. The reports are often 
lengthy 8000 plus page documents70 that are often incomplete and cannot be easily 
text-searched because they are provided as an image file. Moreover, using the 
Freedom of Information Act to obtain clinical study reports held by regulatory bodies 
is time-consuming and can take months and sometimes years to gather data22, 
often in a piecemeal fashion. Searching for this type of missing data goes beyond 
the standard procedures recommended by the Cochrane Collaboration and is not 
116 
 
routinely undertaken. This is understandable given both the time required and the 
monetary constraints that review teams will encounter. These issues are highly 
pertinent to the automation of systematic reviews. If the many steps of systematic 
reviewing could be automated this would enable reviewers to make better use of 
resources pursuing and analysing clinical study reports.  
 
7.11   Conclusions 
The growth of research will continue to delay the production of systematic reviews 
and thus incentivise the development and adoption of automation technologies. 
Research teams have demonstrated an enthusiasm to begin developing automation 
technologies, including prototype software that is slowly being advanced into 
consumer level products. The pace of progress may be hindered by several factors 
including the reluctance of funding bodies, responsible for the commissioning of 
systematic reviews, to invest resources to support the development of automation 
technologies, and the absence of collaboration between research teams, 
commissioning bodies, and data repository providers to pursue common goals and 
adopt common standards to facilitate automation.  
 
The research projects conducted, as part of this PhD thesis, have achieved a 
greater understanding of automation processes for systematic reviews. This 
includes the development of a consumer level deduplication product which has 
surpassed current practice, the evaluation and demonstration of the potential 
benefits of semi-automation citation screening, surveying the strengths and 
weaknesses of bibliographic databases to identify published systematic reviews, 
and developing proof of concept research into expediting the screening of citations 
using PICo based title-only screening.     
 
Pursuing strategies to overcome technical barriers and develop proof of concept 
technologies into consumer level products, and replacing manual tasks with semi-
automation, or replacing semi-automation with full automation will expedite research 
and save resources.  Importantly, it will also allow investigators to make better use 
of their time to contextualise and interpret the research findings in relation to current 
practice, and to devote time to investigate the completeness of the evidence through 
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the acquisition and analysis of clinical study reports for the welfare of patients, 
evidence-based medicine and society. 
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Supplementary appendix A  Identifying reviews 
 
Example of citations listed in each database and cross-compared with Truth-
table created in Excel spreadsheet 
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GreaseMonkey scripts used for screen scraping databases to acquire fuller 
citation details 
GreaseMonkey -  Epistemonikos download 
// ==UserScript== 
 // @name Epistemonikos Download All 
 // @namespace http://crebp.net.au 
 // @version 1.0 
 // @description Script to automatically save all results in a Epistemonikos search 
to an RIS file. 
 // @include http://www.epistemonikos.org/en/search?* 
 // @include http://epistemonikos.org/en/search?* 
 // @grant none 
 // @require http://code.jquery.com/jquery-1.11.0.min.js
 // @require http://raw.github.com/eligrey/FileSaver.js/master/FileSaver.js 
 // @require http://medialize.github.io/URI.js/src/URI.min.js 
 // @copyright 2014+, Matt Carter <m@ttcarter.com>
 // @downloadURL 
https://raw2.github.com/CREBP/GreaseMonkey/master/Epistemonikos%20Downl
oad%20All.js 
 // @updateURL 
https://raw2.github.com/CREBP/GreaseMonkey/master/Epistemonikos%20Downl
oad%20All.js 
 // ==/UserScript== 
 $(function() { 
 console.log('SDL', $('#selected_documents_link')) 
 $('#selected_documents_link > p').css('margin-bottom', '10px'); 
 $('<a title="Download all references" class="btn btn-primary btn-sm pull-right" 
href="#"><i class="glyphicon glyphicon-download-alt"></i> Download All</a>')
 .appendTo($('#selected_documents_link > p')) 
 .after(' ') 
 .on('click', function() { 
 if ($.downloadAll && $.downloadAll.refs) { // Already done the work 
 $.downloadAll.generateOutput(); 
 return; 
 } 
 $('#modal-da-progress').remove();
 $('body').append('<div id="modal-da-progress" class="modal">' + 
 '<div class="modal-dialog"><div class="modal-content">' + 
 '<div class="modal-header">' + 
 '<button type="button" class="close" data-dismiss="modal" aria-
hidden="true">&times;</button>' +
 '<h3>Processing references...</h3>' +
 '</div>' + 
 '<div class="modal-body">' + 
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 '<div class="progress progress-striped active">' +
 '<div id="modal-da-progress-bar" class="progress-bar" role="progressbar" aria-
valuenow="0" aria-valuemin="0" aria-valuemax="100" style="width: 0%"></div>' + 
 '</div>' + 
 '<p id="modal-da-progress-text" class="text-center">Preparing...</p>' + 
 '</div>' + 
 '<div class="modal-footer">' + 
 '<a href="#" class="btn btn-danger" data-dismiss="modal">Cancel</a>' + 
 '</div>' + 
 '</div></div>' + 
 '</div>'); 
 $.downloadAll = { 
 pageLink: $('.pagination .next').attr('href').replace(/p=([0-9]+)/, 'p=0'), 
 pageCurrent: 0, 
 pageCount: $('.pagination > li > a').not('.next').last().text(),
 refs: [], 
 pageDownload: function() { 
 $.ajax({ 
 url: $.downloadAll.pageLink.replace(/p=([0-9]+)/, 'p=' + 
$.downloadAll.pageCurrent),
 dataType: 'html', 
 error: function(err,txt) { 
 alert('An error has occured: ' + txt); 
 $('#modal-da-progress').hide();
 }, 
 success: function(data) { 
 if (!$.downloadAll) // Cancelled? 
 return; 
 $('#modal-da-progress-bar').css('width', parseInt(($.downloadAll.pageCurrent / 
$.downloadAll.pageCount) * 100) + '%');
 $('#modal-da-progress-text').text('Processing page ' + $.downloadAll.pageCurrent 
+ ' of ' + $.downloadAll.pageCount); 
 $(data).find('.result').each(function() {
 var me = $(this); 
 $.downloadAll.refs.push({
 url: 'http://www.epistemonikos.org/' + me.find('h3 > a').attr('href'), 
 title: me.find('h3 > a').text(), 
 authors: me.find('.result-metadata > .authors .author').map(function() { return 
$(this).text() }), 
 journal: me.find('.result-metadata > #journal > span').last().text(), 
 version: me.find('.result-metadata > #year > span').last().text() 
 }); 
 }); 
 if (++$.downloadAll.pageCurrent > $.downloadAll.pageCount) { 
 $('#modal-da-progress-bar').css('width', '100%');
 $('#modal-da-progress-text').text('Compiling results'); 
130 
 
 setTimeout(function() { 
 $('#modal-da-progress').hide(); 
 }, 2000); 
 $.downloadAll.generateOutput(); 
 } else { 
 $.downloadAll.pageDownload();
 } 
 } 
 }); 
 }, 
 cancel: function() { 
 $.downloadAll = null; 
 $('#modal-da-progress').hide(); 
 }, 
 translateVersion: function(str) {
 var months = 
{'January':1,'February':2,'March':3,'April':4,'May':5,'June':6,'July':7,'August':8,'Sept
ember':9,'October':10,'November':11,'December':12}; 
 var matches = /^([A-Z][a-z]+) ([0-9]+)$/.exec(str);
 if (matches) 
 return matches[2] + '/' + months[matches[1]] + '//';
 matches = /^([0-9]+)$/.exec(str); 
 if (matches) 
 return matches[1] + '///'; 
 return ''; 
 }, 
 generateOutput: function() { 
 var out = []; 
 for (var x = 0; x < $.downloadAll.refs.length; x++) {
 var info = "TY - ELEC\n";
 for (var a = 0; a < $.downloadAll.refs[x].authors.length; a++) 
 info += "AU - " + $.downloadAll.refs[x].authors[a] + "\n"; 
 info += 
 "PY - " + $.downloadAll.translateVersion($.downloadAll.refs[x].version) + "\n" +
 "TI - " + $.downloadAll.refs[x].title + "\n" +
 "JO - " + $.downloadAll.refs[x].journal + "\n" + 
 "DO - " + $.downloadAll.refs[x].url + "\n" + 
 "ER - \n"; 
 out.push(info); 
 } 
 var blob = new Blob(out, {type: "text/plain;charset=utf-8"}); 
 saveAs(blob, "Epistemonikos.ris"); 
 } 
 }; 
 $('#modal-da-progress') 
 .on('hide.bs.modal', $.downloadAll.cancel) 
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 .on('click', '[data-dismiss="modal"]', $.downloadAll.cancel)
 .show(); 
 $.downloadAll.pageDownload(); // Start everything 
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GreaseMonkey - PubMed Health download  
// ==UserScript== 
 // @name PubMed Health Download All
 // @namespace http://crebp.net.au 
 // @version 1.0 
 // @description Script to automatically save all results in a PubMed Health search 
to an RIS file. 
 // @include http://www.ncbi.nlm.nih.gov/pubmedhealth/*
 // @include https://www.ncbi.nlm.nih.gov/pubmedhealth/* 
 // @grant none 
 // @require http://code.jquery.com/jquery-1.11.0.min.js
 // @require http://raw.github.com/eligrey/FileSaver.js/master/FileSaver.js 
 // @require http://medialize.github.io/URI.js/src/URI.min.js 
 // @require http://netdna.bootstrapcdn.com/bootstrap/3.1.1/js/bootstrap.min.js 
 // @copyright 2014+, Matt Carter <m@ttcarter.com> 
 // @downloadURL 
https://raw2.github.com/CREBP/GreaseMonkey/master/PubMed%20Health%20
Download%20All.js 
 // @updateURL 
https://raw2.github.com/CREBP/GreaseMonkey/master/PubMed%20Health%20
Download%20All.js 
 // ==/UserScript== 
 $(function() { 
 $('body') 
 .prepend('<link rel="stylesheet" 
href="http://netdna.bootstrapcdn.com/bootstrap/3.1.1/css/bootstrap.min.css" 
type="text/css"/>') 
 .css('font-size', '10px'); 
 if (window.location.href.substr(0, 8) == 'https://') // Switch to http:// version 
 window.location.href = window.location.href.replace('https://', 'http://'); 
 $('a[data-value_id]').on('click', function() { // Fix the stupid inline link filter thats 
used on the site 
 var myURI = URI(window.location) 
 .setSearch('filters', $(this).data('value_id')); 
 window.location.replace(myURI.toString());
 }); 
 $('<a title="Download all references" class="active page_link" href="#">Download 
All</a>') 
 .prependTo($('.pagination')) 
 .after(' ') 
 .on('click', function() { 
 if ($.downloadAll && $.downloadAll.refs) { // Already done the work 
 $.downloadAll.generateOutput(); 
 return; 
 } 
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 $('#modal-da-progress').remove();
 $('body').append('<div id="modal-da-progress" class="modal fade">' + 
 '<div class="modal-dialog"><div class="modal-content">' + 
 '<div class="modal-header">' + 
 '<button type="button" class="close" data-dismiss="modal" aria-
hidden="true">&times;</button>' +
 '<h3>Processing references...</h3>' + 
 '</div>' + 
 '<div class="modal-body">' +
 '<div class="progress progress-striped active">' +
 '<div id="modal-da-progress-bar" class="progress-bar" role="progressbar" aria-
valuenow="0" aria-valuemin="0" aria-valuemax="100" style="width: 0%"></div>' + 
 '</div>' + 
 '<p id="modal-da-progress-text" class="text-center">Preparing...</p>' + 
 '</div>' + 
 '<div class="modal-footer">' +
 '<a href="#" class="btn btn-danger" data-dismiss="modal">Cancel</a>' + 
 '</div>' + 
 '</div></div>' + 
 '</div>'); 
 $.downloadAll = { 
 pageLink: $('.page_link.next').attr('href').replace(/page=([0-9]+)/, 'page=1'), 
 pageCurrent: 1, 
 pageCount: $('.pagination .page_link:last').attr('page'),
 refs: [], 
 pageDownload: function() { 
 $.ajax({ 
 url: $.downloadAll.pageLink.replace(/page=([0-9]+)/, 'page=' + 
$.downloadAll.pageCurrent),
 dataType: 'html', 
 error: function(err,txt) { 
 alert('An error has occured: ' + txt); 
 $('#modal-da-progress').modal('hide');
 }, 
 success: function(data) {
 if (!$.downloadAll) // Cancelled? 
 return; 
 $('#modal-da-progress-bar').css('width', parseInt(($.downloadAll.pageCurrent / 
$.downloadAll.pageCount) * 100) + '%');
 $('#modal-da-progress-text').text('Processing page ' + $.downloadAll.pageCurrent 
+ ' of ' + $.downloadAll.pageCount); 
 $(data).find('.rprt > .rslt').each(function() { 
 var me = $(this); 
 $.downloadAll.refs.push({
 url: 'http://www.ncbi.nlm.nih.gov/' + me.find('.title > a').attr('href'), 
 title: me.find('.title > a').text(), 
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 author: me.find('.supp > .details').text(),
 version: me.find('.rprtid').text() 
 }); 
 }); 
 if (++$.downloadAll.pageCurrent > $.downloadAll.pageCount) { 
 $('#modal-da-progress-bar').css('width', '100%');
 $('#modal-da-progress-text').text('Compiling results'); 
 setTimeout(function() { 
 $('#modal-da-progress').modal('hide');
 }, 2000); 
 $.downloadAll.generateOutput();
 } else { 
 $.downloadAll.pageDownload(); 
 } 
 } 
 }); 
 }, 
 cancel: function() { 
 $.downloadAll = null; 
 }, 
 translateVersion: function(str) {
 var months = 
{'January':1,'February':2,'March':3,'April':4,'May':5,'June':6,'July':7,'August':8,'Sept
ember':9,'October':10,'November':11,'December':12};
 var matches = /^Version: ([A-Z][a-z]+) ([0-9]+)$/.exec(str);
 if (matches) 
 return matches[2] + '/' + months[matches[1]] + '//'; 
 matches = /^Version: ([0-9]+)$/.exec(str); 
 if (matches) 
 return matches[1] + '///'; 
 return ''; 
 }, 
 generateOutput: function() {
 var out = []; 
 for (var x = 0; x < $.downloadAll.refs.length; x++) {
 out.push( 
 "TY - ELEC\n" + 
 "AU - " + $.downloadAll.refs[x].author + "\n" +
 "PY - " + $.downloadAll.translateVersion($.downloadAll.refs[x].version) + "\n" +
 "TI - " + $.downloadAll.refs[x].title + "\n" +
 "DO - " + $.downloadAll.refs[x].url + "\n" + 
 "ER - \n" 
 ); 
 } 
 var blob = new Blob(out, {type: "text/plain;charset=utf-8"});
 saveAs(blob, "PubMed Health.ris"); 
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 } 
 }; 
 $('#modal-da-progress') 
 .on('hide.bs.modal', $.downloadAll.cancel) 
 .modal('show'); 
 $.downloadAll.pageDownload(); // Start everything
 }); 
 }); 
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GreaseMonkey - TRIP download  
 
// ==UserScript== 
 // @name TripDatabase.com Download All 
 // @namespace http://crebp.net.au 
 // @version 1.0 
 // @description Script to automatically save all results in a TripDatabase search 
to an RIS file. 
 // @include http://www.tripdatabase.com/search?* 
 // @include http://tripdatabase.com/search?* 
 // @grant none 
 // @require http://medialize.github.io/URI.js/src/URI.min.js 
 // @copyright 2014+, Matt Carter <m@ttcarter.com> 
 // @downloadURL 
https://raw2.github.com/CREBP/GreaseMonkey/master/TripDatabase.com%20D
ownload%20All.js 
 // @updateURL 
https://raw2.github.com/CREBP/GreaseMonkey/master/TripDatabase.com%20D
ownload%20All.js 
 // ==/UserScript== 
  $(function() { 
 $('<a class="btn"><i class="icon icon-download" style="font-size: 13px"></i> 
Download All</a>') 
 .appendTo($('#results .results-meta')) 
 .before(' ') 
 .on('click', function() { 
 var myURI = URI(window.location) 
 .addSearch('max', '999999') 
 .path('/search/ris'); 
 window.location.replace(myURI.toString()); 
 }); 
 }); 
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Supplementary appendix B   Deduplication 
 
Additional methods 
Creation of an Endnote library 
In Endnote (X6, Thomson Reuters, USA), a library was created by selecting 
columns to display relevant fields to aid with the identification of unique and 
duplicate records. The fields chosen were: Author, Year, Title, Journal, Volume, 
Page number, Caption (used for record ID), and Notes and Language fields. The 
Notes field was used to enter coding for the benchmark (‘Gold standard’) to 
compare the performance of Endnote and the SRA-DM algorithm according to 
whether the record was unique or a duplicate, and whether the assigned duplicate 
record was identified correctly i.e. a genuine duplicate or a wrongly identified 
duplicate. The Language field was used to populate the decisions made by the 
SRA-DM algorithm. 
  
Definitions 
A duplicate record was defined as being the same bibliographic record (irrespective 
of how the citation details were reported, e.g. variations in page numbers, author 
details, accents used, or abridged titles).  Where data from a single study was 
reported in several publications, these were not classed as duplicates, as they are 
multiple reports which can appear across or within journals. Similarly, where 
different publications report the exact data, e.g. journal and conference proceedings, 
these were treated as separate bibliographic records.  
 
Benchmark 
A dataset of 1988 records derived from a search conducted on 29th July 2013 for 
surgical and non-surgical management for pleural empyema was used to evaluate 
Endnote and SRA-DM algorithm.  Six databases were searched (Box 1).  
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Coding citations: identified as duplicates by Endnote 
The 1988 records were imported into Endnote library and duplicate records were 
sought using the automated ‘Find Duplicates’ command in Endnote.  The default 
Endnote setting (‘author’, ‘year’, ‘title’) was used to match the records. The records 
returned as duplicates were visually inspected to check the accuracy, i.e. that all 
contained at least one duplicate. These records were coded in the Notes field as 
either Endnote Main (EM) duplicate, or Endnote True (ET) duplicate, i.e. ET being a 
true duplicate of EM. The first duplicate record to be identified (alphabetically sorted 
by author) was designated EM and its associated duplicate record(s) were coded as 
ET.  Where records were incorrectly identified as being a duplicate, these were 
 
Box 1. Search dates 
 Medline (Ovid) searched from 1946 to July week 3 2013 
  
           EMBASE searched from 2010 to July 2013 (all EMBASE RCTs 
           prior to 2010 are now in CENTRAL) 
 CENTRAL searched July 2013 Issue 7  
 
 
 CINAHL searched from 1981 to July 2013  
 
 LILACS searched from 1982 to July 2013  
 
 
 PUBMED searched July 2013 (searched to find any citations 
not listed in MEDLINE) 
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coded as (EF), i.e. Endnote False duplicate. 
 
Coding citations: identified as NOT duplicates by Endnote  
The remaining records (not identified by Endnote as duplicates) were alphabetically 
ordered according to first author’s name and then visually inspected to identify 
additional duplicate records. These records were coded in the Notes field as follows: 
if a record was identified as a further duplicate of EM, it was coded (DEM) i.e. 
Duplicate of Endnote Main; unique records were coded as (U). Duplicates existing 
only in the remaining records and not related to those duplicates identified by 
Endnote were coded as Original Duplicate (OD) and DOD, i.e. a Duplicate of OD.   
 
Duplicate records could potentially go undetected in scenarios where first author 
names are misspelt or reported in a different order.  Therefore, to avoid missed 
duplicates, the database was also alphabetically re-ordered according to the study 
titles and reinspected for duplicate records, before finalising the classification of 
records.  This thorough process of labelling and double-checking each record 
reduced the likelihood of missing duplicates whilst establishing a benchmark against 
which the results of Endnote and the SRA-DM algorithm could be compared, and 
any anomalies could be pinpointed down to an individual record level. Therefore, 
each record was classified into one of the seven possible categories (Table 1). 
 
 
Table 1.  Individual record coding and definitions  
  
  
Coding Classification 
EM Endnote Main duplicate (identified correctly as a duplicate by Endnote) 
ET Endnote True duplicate of EM (identified correctly as an associated 
duplicate by Endnote) 
EF Endnote False duplicate of EM (incorrectly identified as a duplicate by 
Endnote)   
U Unique reference 
DEM Duplicate of EM (duplicate missed by Endnote) 
OD Original Duplicate (duplicate missed by Endnote) 
DOD Duplicate of OD (duplicate missed by Endnote) 
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Smart group filtering 
To assess the performance of Endnote deduplication, the smart groups filtering 
facility within Endnote was used to further classify the 7 types of records into 4 main 
groups (Table 2): True Positives (EM and ET), False Positives (EF), True Negatives 
(U), and False Negatives (OD, DOD and DEM).  These values were used to 
generate the sensitivity and specificity. 
 
 
Table 2. Smart Group coding and definition 
Group Group characteristic 
True Positive TP True duplicate or correctly identified duplicate (EM or ET) 
False Positive FP False duplicate or incorrectly identified duplicate (EF) 
True Negative TN Unique record, correctly identified as non-duplicate (U) 
False Negative 
FN 
True duplicate, incorrectly identified as non-duplicate (OD, 
DOD or DEM) 
 
Coding citations identified as duplicates by SRA 
The SRA-DM algorithm identified and coded duplicate records automatically using a 
binary code - either ‘OK’ for either a unique record, or a record identified as a first 
duplicate, or ‘DUPE’ where the second or multiple duplicates were identified.  The 
term ‘OK’ indicated that the record may be relevant and should be retained, whilst 
‘DUPE’ signified a record that would be discarded.  
 
The first step in validating the system was to filter out all ‘OK’ records designated by 
SRA-DM algorithm that corresponded to the unique (U) benchmark records, using 
the Create Smart Group facility in Endnote, and classifying them as True Negative 
(TN).  This constituted the majority of the records.  The remaining records were then 
visually and manually cross-checked against the benchmark coding to determine 
the accuracy of the SRA-DM algorithm.    
143 
 
 
Each record coded correctly as ‘OK’ corresponds to either a unique record (U), the 
main duplicate reference (EM) or a record incorrectly marked as duplicate by 
Endnote (EF), and these combinations were labelled as TN (True Negative).  A 
correctly coded ‘DUPE’ corresponds to either the associated original duplicate 
records (OD) or to a redundant duplicate (ET, DEM or DOD).  These were labelled 
TP (True Positive).  The remaining records were marked as either FN or FP, as 
appropriate.  Hence, where SRA-DM algorithm correctly matched according to the 
benchmark coding these were coded as either TP (True Positive), i.e. correctly 
identified duplicates, FP (False Positive), i.e. incorrectly identified duplicates, FN 
(False Negative), i.e. incorrectly identified unique records or TN (True Negative) for 
correctly identified unique records.  
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Supplementary appendix C  Predictive screening 
(Abstrackr) 
Example of training values (labels) applied to citations during the training phase in 
Abstrackr. 
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Example of Abstrackr prediction probabilities 
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Example of Abstrackr prediction probabilities and hard screening predictions 
 
